<?xml version="1.0" encoding="UTF-8"?>
<?xml-stylesheet type="text/xsl" media="screen" href="/~d/styles/rss2full.xsl"?><?xml-stylesheet type="text/css" media="screen" href="http://feeds.feedburner.com/~d/styles/itemcontent.css"?><rss xmlns:feedburner="http://rssnamespace.org/feedburner/ext/1.0" version="2.0"><channel><title>Latest EPG Online News</title><link>http://www.epgonline.org/drug-news.cfm</link><description>Latest Drug News From EPGOnline.org</description> 
<atom10:link xmlns:atom10="http://www.w3.org/2005/Atom" rel="self" type="application/rss+xml" href="http://feeds.feedburner.com/LatestEpgOnlineNews" /><feedburner:info uri="latestepgonlinenews" /><atom10:link xmlns:atom10="http://www.w3.org/2005/Atom" rel="hub" href="http://pubsubhubbub.appspot.com/" /><image><link>http://www.epgonline.org</link><url>http://development.epgonline.org/rss/img-epg.jpg</url></image><feedburner:emailServiceId>LatestEpgOnlineNews</feedburner:emailServiceId><feedburner:feedburnerHostname>http://feedburner.google.com</feedburner:feedburnerHostname><item>
<title>Results positive for Afinitor (Novartis) in BOLERO-3 study in  HER2 positive Breast Cancer</title>
<link>http://feedproxy.google.com/~r/LatestEpgOnlineNews/~3/_t1up5KN9G8/Results-positive-for-Afinitor-Novartis-.cfm</link>
<category>Breast Cancer</category>
<pubDate>Sun, 19 May 2013 00:05:00 GMT</pubDate>
<description>&lt;div class="feedflare"&gt;
&lt;a href="http://feeds.feedburner.com/~ff/LatestEpgOnlineNews?a=_t1up5KN9G8:AFI4XuDgFgI:yIl2AUoC8zA"&gt;&lt;img src="http://feeds.feedburner.com/~ff/LatestEpgOnlineNews?d=yIl2AUoC8zA" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/LatestEpgOnlineNews?a=_t1up5KN9G8:AFI4XuDgFgI:V_sGLiPBpWU"&gt;&lt;img src="http://feeds.feedburner.com/~ff/LatestEpgOnlineNews?i=_t1up5KN9G8:AFI4XuDgFgI:V_sGLiPBpWU" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/LatestEpgOnlineNews?a=_t1up5KN9G8:AFI4XuDgFgI:qj6IDK7rITs"&gt;&lt;img src="http://feeds.feedburner.com/~ff/LatestEpgOnlineNews?d=qj6IDK7rITs" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/LatestEpgOnlineNews?a=_t1up5KN9G8:AFI4XuDgFgI:gIN9vFwOqvQ"&gt;&lt;img src="http://feeds.feedburner.com/~ff/LatestEpgOnlineNews?i=_t1up5KN9G8:AFI4XuDgFgI:gIN9vFwOqvQ" border="0"&gt;&lt;/img&gt;&lt;/a&gt;
&lt;/div&gt;&lt;img src="http://feeds.feedburner.com/~r/LatestEpgOnlineNews/~4/_t1up5KN9G8" height="1" width="1"/&gt;</description><feedburner:origLink>http://www.epgonline.org/news/2013/May/Results-positive-for-Afinitor-Novartis-.cfm</feedburner:origLink></item>

<item>
<title>Study of Prolia (Amgen/GSK) plus teriparatide shows significant benefits in Osteoporosis</title>
<link>http://feedproxy.google.com/~r/LatestEpgOnlineNews/~3/u5x5SWoB5YM/Study-of-Prolia-Amgen-GSK-plus.cfm</link>
<category>Osteoporosis</category>
<pubDate>Sun, 19 May 2013 00:05:00 GMT</pubDate>
<description>&lt;div class="feedflare"&gt;
&lt;a href="http://feeds.feedburner.com/~ff/LatestEpgOnlineNews?a=u5x5SWoB5YM:oIwtbAx8R-g:yIl2AUoC8zA"&gt;&lt;img src="http://feeds.feedburner.com/~ff/LatestEpgOnlineNews?d=yIl2AUoC8zA" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/LatestEpgOnlineNews?a=u5x5SWoB5YM:oIwtbAx8R-g:V_sGLiPBpWU"&gt;&lt;img src="http://feeds.feedburner.com/~ff/LatestEpgOnlineNews?i=u5x5SWoB5YM:oIwtbAx8R-g:V_sGLiPBpWU" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/LatestEpgOnlineNews?a=u5x5SWoB5YM:oIwtbAx8R-g:qj6IDK7rITs"&gt;&lt;img src="http://feeds.feedburner.com/~ff/LatestEpgOnlineNews?d=qj6IDK7rITs" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/LatestEpgOnlineNews?a=u5x5SWoB5YM:oIwtbAx8R-g:gIN9vFwOqvQ"&gt;&lt;img src="http://feeds.feedburner.com/~ff/LatestEpgOnlineNews?i=u5x5SWoB5YM:oIwtbAx8R-g:gIN9vFwOqvQ" border="0"&gt;&lt;/img&gt;&lt;/a&gt;
&lt;/div&gt;&lt;img src="http://feeds.feedburner.com/~r/LatestEpgOnlineNews/~4/u5x5SWoB5YM" height="1" width="1"/&gt;</description><feedburner:origLink>http://www.epgonline.org/news/2013/May/Study-of-Prolia-Amgen-GSK-plus.cfm</feedburner:origLink></item>

<item>
<title>SAR 302503 (Sanofi) successs in JAKARTA study of Myelofibrosis</title>
<link>http://feedproxy.google.com/~r/LatestEpgOnlineNews/~3/_t6gF3sx9eI/SAR-302503-Sanofi-successsin.cfm</link>
<category>Myelofibrosis</category>
<pubDate>Sat, 18 May 2013 00:05:00 GMT</pubDate>
<description>&lt;div class="feedflare"&gt;
&lt;a href="http://feeds.feedburner.com/~ff/LatestEpgOnlineNews?a=_t6gF3sx9eI:cYIxLBsNwJ8:yIl2AUoC8zA"&gt;&lt;img src="http://feeds.feedburner.com/~ff/LatestEpgOnlineNews?d=yIl2AUoC8zA" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/LatestEpgOnlineNews?a=_t6gF3sx9eI:cYIxLBsNwJ8:V_sGLiPBpWU"&gt;&lt;img src="http://feeds.feedburner.com/~ff/LatestEpgOnlineNews?i=_t6gF3sx9eI:cYIxLBsNwJ8:V_sGLiPBpWU" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/LatestEpgOnlineNews?a=_t6gF3sx9eI:cYIxLBsNwJ8:qj6IDK7rITs"&gt;&lt;img src="http://feeds.feedburner.com/~ff/LatestEpgOnlineNews?d=qj6IDK7rITs" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/LatestEpgOnlineNews?a=_t6gF3sx9eI:cYIxLBsNwJ8:gIN9vFwOqvQ"&gt;&lt;img src="http://feeds.feedburner.com/~ff/LatestEpgOnlineNews?i=_t6gF3sx9eI:cYIxLBsNwJ8:gIN9vFwOqvQ" border="0"&gt;&lt;/img&gt;&lt;/a&gt;
&lt;/div&gt;&lt;img src="http://feeds.feedburner.com/~r/LatestEpgOnlineNews/~4/_t6gF3sx9eI" height="1" width="1"/&gt;</description><feedburner:origLink>http://www.epgonline.org/news/2013/May/SAR-302503-Sanofi-successsin.cfm</feedburner:origLink></item>

<item>
<title>Phase III study of NEPA (Helsinn and Eisai) meets endpoint in patients with Nausea</title>
<link>http://feedproxy.google.com/~r/LatestEpgOnlineNews/~3/iRvjNh2u6wA/Phase-III-study-ofNEPA.cfm</link>
<category>Nausea</category>
<pubDate>Sat, 18 May 2013 00:05:00 GMT</pubDate>
<description>&lt;div class="feedflare"&gt;
&lt;a href="http://feeds.feedburner.com/~ff/LatestEpgOnlineNews?a=iRvjNh2u6wA:qI4HKmyVOh8:yIl2AUoC8zA"&gt;&lt;img src="http://feeds.feedburner.com/~ff/LatestEpgOnlineNews?d=yIl2AUoC8zA" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/LatestEpgOnlineNews?a=iRvjNh2u6wA:qI4HKmyVOh8:V_sGLiPBpWU"&gt;&lt;img src="http://feeds.feedburner.com/~ff/LatestEpgOnlineNews?i=iRvjNh2u6wA:qI4HKmyVOh8:V_sGLiPBpWU" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/LatestEpgOnlineNews?a=iRvjNh2u6wA:qI4HKmyVOh8:qj6IDK7rITs"&gt;&lt;img src="http://feeds.feedburner.com/~ff/LatestEpgOnlineNews?d=qj6IDK7rITs" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/LatestEpgOnlineNews?a=iRvjNh2u6wA:qI4HKmyVOh8:gIN9vFwOqvQ"&gt;&lt;img src="http://feeds.feedburner.com/~ff/LatestEpgOnlineNews?i=iRvjNh2u6wA:qI4HKmyVOh8:gIN9vFwOqvQ" border="0"&gt;&lt;/img&gt;&lt;/a&gt;
&lt;/div&gt;&lt;img src="http://feeds.feedburner.com/~r/LatestEpgOnlineNews/~4/iRvjNh2u6wA" height="1" width="1"/&gt;</description><feedburner:origLink>http://www.epgonline.org/news/2013/May/Phase-III-study-ofNEPA.cfm</feedburner:origLink></item>

<item>
<title>Phase III study of Tomtovok (Boehringer) meets endpoint for NSCLC</title>
<link>http://feedproxy.google.com/~r/LatestEpgOnlineNews/~3/jnXq8rtBmNM/Phase-III-study-ofTomtovok.cfm</link>
<category>Non Small Cell Lung Cancer</category>
<pubDate>Sat, 18 May 2013 00:05:00 GMT</pubDate>
<description>&lt;div class="feedflare"&gt;
&lt;a href="http://feeds.feedburner.com/~ff/LatestEpgOnlineNews?a=jnXq8rtBmNM:2H5NL4vDNIU:yIl2AUoC8zA"&gt;&lt;img src="http://feeds.feedburner.com/~ff/LatestEpgOnlineNews?d=yIl2AUoC8zA" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/LatestEpgOnlineNews?a=jnXq8rtBmNM:2H5NL4vDNIU:V_sGLiPBpWU"&gt;&lt;img src="http://feeds.feedburner.com/~ff/LatestEpgOnlineNews?i=jnXq8rtBmNM:2H5NL4vDNIU:V_sGLiPBpWU" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/LatestEpgOnlineNews?a=jnXq8rtBmNM:2H5NL4vDNIU:qj6IDK7rITs"&gt;&lt;img src="http://feeds.feedburner.com/~ff/LatestEpgOnlineNews?d=qj6IDK7rITs" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/LatestEpgOnlineNews?a=jnXq8rtBmNM:2H5NL4vDNIU:gIN9vFwOqvQ"&gt;&lt;img src="http://feeds.feedburner.com/~ff/LatestEpgOnlineNews?i=jnXq8rtBmNM:2H5NL4vDNIU:gIN9vFwOqvQ" border="0"&gt;&lt;/img&gt;&lt;/a&gt;
&lt;/div&gt;&lt;img src="http://feeds.feedburner.com/~r/LatestEpgOnlineNews/~4/jnXq8rtBmNM" height="1" width="1"/&gt;</description><feedburner:origLink>http://www.epgonline.org/news/2013/May/Phase-III-study-ofTomtovok.cfm</feedburner:origLink></item>

<item>
<title>IDMC halts Phase III study of Vargatef (Boehringer) in NSCLC</title>
<link>http://feedproxy.google.com/~r/LatestEpgOnlineNews/~3/cEG26QhqJwQ/IDMC-halts-Phase-IIIstudy.cfm</link>
<category>Non Small Cell Lung Cancer</category>
<pubDate>Sat, 18 May 2013 00:05:00 GMT</pubDate>
<description>&lt;div class="feedflare"&gt;
&lt;a href="http://feeds.feedburner.com/~ff/LatestEpgOnlineNews?a=cEG26QhqJwQ:LueHfGT_cNI:yIl2AUoC8zA"&gt;&lt;img src="http://feeds.feedburner.com/~ff/LatestEpgOnlineNews?d=yIl2AUoC8zA" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/LatestEpgOnlineNews?a=cEG26QhqJwQ:LueHfGT_cNI:V_sGLiPBpWU"&gt;&lt;img src="http://feeds.feedburner.com/~ff/LatestEpgOnlineNews?i=cEG26QhqJwQ:LueHfGT_cNI:V_sGLiPBpWU" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/LatestEpgOnlineNews?a=cEG26QhqJwQ:LueHfGT_cNI:qj6IDK7rITs"&gt;&lt;img src="http://feeds.feedburner.com/~ff/LatestEpgOnlineNews?d=qj6IDK7rITs" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/LatestEpgOnlineNews?a=cEG26QhqJwQ:LueHfGT_cNI:gIN9vFwOqvQ"&gt;&lt;img src="http://feeds.feedburner.com/~ff/LatestEpgOnlineNews?i=cEG26QhqJwQ:LueHfGT_cNI:gIN9vFwOqvQ" border="0"&gt;&lt;/img&gt;&lt;/a&gt;
&lt;/div&gt;&lt;img src="http://feeds.feedburner.com/~r/LatestEpgOnlineNews/~4/cEG26QhqJwQ" height="1" width="1"/&gt;</description><feedburner:origLink>http://www.epgonline.org/news/2013/May/IDMC-halts-Phase-IIIstudy.cfm</feedburner:origLink></item>

<item>
<title>EU Pharmacovigilance Risk Assessment Committee clears Diane 35 (Bayer) for Acne</title>
<link>http://feedproxy.google.com/~r/LatestEpgOnlineNews/~3/eVmGdDf8aAs/EU-Pharmacovigilance-Risk-AssessmentCommittee.cfm</link>
<category>Acne</category>
<pubDate>Sat, 18 May 2013 00:05:00 GMT</pubDate>
<description>&lt;div class="feedflare"&gt;
&lt;a href="http://feeds.feedburner.com/~ff/LatestEpgOnlineNews?a=eVmGdDf8aAs:8cBE_zHg4qE:yIl2AUoC8zA"&gt;&lt;img src="http://feeds.feedburner.com/~ff/LatestEpgOnlineNews?d=yIl2AUoC8zA" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/LatestEpgOnlineNews?a=eVmGdDf8aAs:8cBE_zHg4qE:V_sGLiPBpWU"&gt;&lt;img src="http://feeds.feedburner.com/~ff/LatestEpgOnlineNews?i=eVmGdDf8aAs:8cBE_zHg4qE:V_sGLiPBpWU" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/LatestEpgOnlineNews?a=eVmGdDf8aAs:8cBE_zHg4qE:qj6IDK7rITs"&gt;&lt;img src="http://feeds.feedburner.com/~ff/LatestEpgOnlineNews?d=qj6IDK7rITs" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/LatestEpgOnlineNews?a=eVmGdDf8aAs:8cBE_zHg4qE:gIN9vFwOqvQ"&gt;&lt;img src="http://feeds.feedburner.com/~ff/LatestEpgOnlineNews?i=eVmGdDf8aAs:8cBE_zHg4qE:gIN9vFwOqvQ" border="0"&gt;&lt;/img&gt;&lt;/a&gt;
&lt;/div&gt;&lt;img src="http://feeds.feedburner.com/~r/LatestEpgOnlineNews/~4/eVmGdDf8aAs" height="1" width="1"/&gt;</description><feedburner:origLink>http://www.epgonline.org/news/2013/May/EU-Pharmacovigilance-Risk-AssessmentCommittee.cfm</feedburner:origLink></item>

<item>
<title>Phase III trial for N9-GP(Novo Nordisk) treatment for Haemophilia B</title>
<link>http://feedproxy.google.com/~r/LatestEpgOnlineNews/~3/owhtqxgvWps/Phase-III-trial-forN9-GP-Novo.cfm</link>
<category>Haemophilia</category>
<pubDate>Sat, 18 May 2013 00:05:00 GMT</pubDate>
<description>&lt;div class="feedflare"&gt;
&lt;a href="http://feeds.feedburner.com/~ff/LatestEpgOnlineNews?a=owhtqxgvWps:oUW3uQ2AlJA:yIl2AUoC8zA"&gt;&lt;img src="http://feeds.feedburner.com/~ff/LatestEpgOnlineNews?d=yIl2AUoC8zA" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/LatestEpgOnlineNews?a=owhtqxgvWps:oUW3uQ2AlJA:V_sGLiPBpWU"&gt;&lt;img src="http://feeds.feedburner.com/~ff/LatestEpgOnlineNews?i=owhtqxgvWps:oUW3uQ2AlJA:V_sGLiPBpWU" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/LatestEpgOnlineNews?a=owhtqxgvWps:oUW3uQ2AlJA:qj6IDK7rITs"&gt;&lt;img src="http://feeds.feedburner.com/~ff/LatestEpgOnlineNews?d=qj6IDK7rITs" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/LatestEpgOnlineNews?a=owhtqxgvWps:oUW3uQ2AlJA:gIN9vFwOqvQ"&gt;&lt;img src="http://feeds.feedburner.com/~ff/LatestEpgOnlineNews?i=owhtqxgvWps:oUW3uQ2AlJA:gIN9vFwOqvQ" border="0"&gt;&lt;/img&gt;&lt;/a&gt;
&lt;/div&gt;&lt;img src="http://feeds.feedburner.com/~r/LatestEpgOnlineNews/~4/owhtqxgvWps" height="1" width="1"/&gt;</description><feedburner:origLink>http://www.epgonline.org/news/2013/May/Phase-III-trial-forN9-GP-Novo.cfm</feedburner:origLink></item>

<item>
<title>TaiGen Biotechnology files NDA for antibiotic nemonoxacin in Taiwan and China</title>
<link>http://feedproxy.google.com/~r/LatestEpgOnlineNews/~3/-8kKRHWju6I/TaiGen-Biotechnology-files-NDAfor.cfm</link>
<category>Infectious Diseases</category>
<pubDate>Fri, 17 May 2013 00:05:00 GMT</pubDate>
<description>&lt;div class="feedflare"&gt;
&lt;a href="http://feeds.feedburner.com/~ff/LatestEpgOnlineNews?a=-8kKRHWju6I:Lvr7tgxx09Q:yIl2AUoC8zA"&gt;&lt;img src="http://feeds.feedburner.com/~ff/LatestEpgOnlineNews?d=yIl2AUoC8zA" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/LatestEpgOnlineNews?a=-8kKRHWju6I:Lvr7tgxx09Q:V_sGLiPBpWU"&gt;&lt;img src="http://feeds.feedburner.com/~ff/LatestEpgOnlineNews?i=-8kKRHWju6I:Lvr7tgxx09Q:V_sGLiPBpWU" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/LatestEpgOnlineNews?a=-8kKRHWju6I:Lvr7tgxx09Q:qj6IDK7rITs"&gt;&lt;img src="http://feeds.feedburner.com/~ff/LatestEpgOnlineNews?d=qj6IDK7rITs" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/LatestEpgOnlineNews?a=-8kKRHWju6I:Lvr7tgxx09Q:gIN9vFwOqvQ"&gt;&lt;img src="http://feeds.feedburner.com/~ff/LatestEpgOnlineNews?i=-8kKRHWju6I:Lvr7tgxx09Q:gIN9vFwOqvQ" border="0"&gt;&lt;/img&gt;&lt;/a&gt;
&lt;/div&gt;&lt;img src="http://feeds.feedburner.com/~r/LatestEpgOnlineNews/~4/-8kKRHWju6I" height="1" width="1"/&gt;</description><feedburner:origLink>http://www.epgonline.org/news/2013/May/TaiGen-Biotechnology-files-NDAfor.cfm</feedburner:origLink></item>

<item>
<title>FDA approves Xofigo (Bayer HealthCare) for Prostate Cancer</title>
<link>http://feedproxy.google.com/~r/LatestEpgOnlineNews/~3/Bytflj77teQ/FDA-approves-Xofigo-BayerHealthCare-.cfm</link>
<category>Prostate Cancer</category>
<pubDate>Fri, 17 May 2013 00:05:00 GMT</pubDate>
<description>&lt;div class="feedflare"&gt;
&lt;a href="http://feeds.feedburner.com/~ff/LatestEpgOnlineNews?a=Bytflj77teQ:NCyMbsRcqFk:yIl2AUoC8zA"&gt;&lt;img src="http://feeds.feedburner.com/~ff/LatestEpgOnlineNews?d=yIl2AUoC8zA" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/LatestEpgOnlineNews?a=Bytflj77teQ:NCyMbsRcqFk:V_sGLiPBpWU"&gt;&lt;img src="http://feeds.feedburner.com/~ff/LatestEpgOnlineNews?i=Bytflj77teQ:NCyMbsRcqFk:V_sGLiPBpWU" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/LatestEpgOnlineNews?a=Bytflj77teQ:NCyMbsRcqFk:qj6IDK7rITs"&gt;&lt;img src="http://feeds.feedburner.com/~ff/LatestEpgOnlineNews?d=qj6IDK7rITs" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/LatestEpgOnlineNews?a=Bytflj77teQ:NCyMbsRcqFk:gIN9vFwOqvQ"&gt;&lt;img src="http://feeds.feedburner.com/~ff/LatestEpgOnlineNews?i=Bytflj77teQ:NCyMbsRcqFk:gIN9vFwOqvQ" border="0"&gt;&lt;/img&gt;&lt;/a&gt;
&lt;/div&gt;&lt;img src="http://feeds.feedburner.com/~r/LatestEpgOnlineNews/~4/Bytflj77teQ" height="1" width="1"/&gt;</description><feedburner:origLink>http://www.epgonline.org/news/2013/May/FDA-approves-Xofigo-BayerHealthCare-.cfm</feedburner:origLink></item>

<item>
<title>Moxetumomab (MedImmune/AstraZeneca) moves into Phase III for Treatment of Hairy Cell Leukemia</title>
<link>http://feedproxy.google.com/~r/LatestEpgOnlineNews/~3/J8TkTGx3mtc/Moxetumomab-MedImmune-AstraZeneca-moves-intoPhase.cfm</link>
<category>Hairy Cell Leukemia</category>
<pubDate>Fri, 17 May 2013 00:05:00 GMT</pubDate>
<description>&lt;div class="feedflare"&gt;
&lt;a href="http://feeds.feedburner.com/~ff/LatestEpgOnlineNews?a=J8TkTGx3mtc:YxJDRWyl3Yc:yIl2AUoC8zA"&gt;&lt;img src="http://feeds.feedburner.com/~ff/LatestEpgOnlineNews?d=yIl2AUoC8zA" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/LatestEpgOnlineNews?a=J8TkTGx3mtc:YxJDRWyl3Yc:V_sGLiPBpWU"&gt;&lt;img src="http://feeds.feedburner.com/~ff/LatestEpgOnlineNews?i=J8TkTGx3mtc:YxJDRWyl3Yc:V_sGLiPBpWU" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/LatestEpgOnlineNews?a=J8TkTGx3mtc:YxJDRWyl3Yc:qj6IDK7rITs"&gt;&lt;img src="http://feeds.feedburner.com/~ff/LatestEpgOnlineNews?d=qj6IDK7rITs" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/LatestEpgOnlineNews?a=J8TkTGx3mtc:YxJDRWyl3Yc:gIN9vFwOqvQ"&gt;&lt;img src="http://feeds.feedburner.com/~ff/LatestEpgOnlineNews?i=J8TkTGx3mtc:YxJDRWyl3Yc:gIN9vFwOqvQ" border="0"&gt;&lt;/img&gt;&lt;/a&gt;
&lt;/div&gt;&lt;img src="http://feeds.feedburner.com/~r/LatestEpgOnlineNews/~4/J8TkTGx3mtc" height="1" width="1"/&gt;</description><feedburner:origLink>http://www.epgonline.org/news/2013/May/Moxetumomab-MedImmune-AstraZeneca-moves-intoPhase.cfm</feedburner:origLink></item>

<item>
<title>FDA approves Tarceva (Genentech/Astellas) for NSCLC as detected by cobas EGFR Mutation Test</title>
<link>http://feedproxy.google.com/~r/LatestEpgOnlineNews/~3/ica5N0gM8bI/FDA-approves-Tarceva-Genentech-Astellas-for.cfm</link>
<category>Non Small Cell Lung Cancer</category>
<pubDate>Thu, 16 May 2013 00:05:00 GMT</pubDate>
<description>&lt;div class="feedflare"&gt;
&lt;a href="http://feeds.feedburner.com/~ff/LatestEpgOnlineNews?a=ica5N0gM8bI:XLKJNMxdH6o:yIl2AUoC8zA"&gt;&lt;img src="http://feeds.feedburner.com/~ff/LatestEpgOnlineNews?d=yIl2AUoC8zA" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/LatestEpgOnlineNews?a=ica5N0gM8bI:XLKJNMxdH6o:V_sGLiPBpWU"&gt;&lt;img src="http://feeds.feedburner.com/~ff/LatestEpgOnlineNews?i=ica5N0gM8bI:XLKJNMxdH6o:V_sGLiPBpWU" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/LatestEpgOnlineNews?a=ica5N0gM8bI:XLKJNMxdH6o:qj6IDK7rITs"&gt;&lt;img src="http://feeds.feedburner.com/~ff/LatestEpgOnlineNews?d=qj6IDK7rITs" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/LatestEpgOnlineNews?a=ica5N0gM8bI:XLKJNMxdH6o:gIN9vFwOqvQ"&gt;&lt;img src="http://feeds.feedburner.com/~ff/LatestEpgOnlineNews?i=ica5N0gM8bI:XLKJNMxdH6o:gIN9vFwOqvQ" border="0"&gt;&lt;/img&gt;&lt;/a&gt;
&lt;/div&gt;&lt;img src="http://feeds.feedburner.com/~r/LatestEpgOnlineNews/~4/ica5N0gM8bI" height="1" width="1"/&gt;</description><feedburner:origLink>http://www.epgonline.org/news/2013/May/FDA-approves-Tarceva-Genentech-Astellas-for.cfm</feedburner:origLink></item>

<item>
<title>Seattle Genetics files Adcetris at FDA for extended use in Hodgkin Lymphoma and sALCL</title>
<link>http://feedproxy.google.com/~r/LatestEpgOnlineNews/~3/s9ytfLpsYSQ/Seattle-Genetics-files-Adcetrisat.cfm</link>
<category>Hodgkin Lymphoma</category>
<pubDate>Thu, 16 May 2013 00:05:00 GMT</pubDate>
<description>&lt;div class="feedflare"&gt;
&lt;a href="http://feeds.feedburner.com/~ff/LatestEpgOnlineNews?a=s9ytfLpsYSQ:I7gK62tKbcQ:yIl2AUoC8zA"&gt;&lt;img src="http://feeds.feedburner.com/~ff/LatestEpgOnlineNews?d=yIl2AUoC8zA" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/LatestEpgOnlineNews?a=s9ytfLpsYSQ:I7gK62tKbcQ:V_sGLiPBpWU"&gt;&lt;img src="http://feeds.feedburner.com/~ff/LatestEpgOnlineNews?i=s9ytfLpsYSQ:I7gK62tKbcQ:V_sGLiPBpWU" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/LatestEpgOnlineNews?a=s9ytfLpsYSQ:I7gK62tKbcQ:qj6IDK7rITs"&gt;&lt;img src="http://feeds.feedburner.com/~ff/LatestEpgOnlineNews?d=qj6IDK7rITs" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/LatestEpgOnlineNews?a=s9ytfLpsYSQ:I7gK62tKbcQ:gIN9vFwOqvQ"&gt;&lt;img src="http://feeds.feedburner.com/~ff/LatestEpgOnlineNews?i=s9ytfLpsYSQ:I7gK62tKbcQ:gIN9vFwOqvQ" border="0"&gt;&lt;/img&gt;&lt;/a&gt;
&lt;/div&gt;&lt;img src="http://feeds.feedburner.com/~r/LatestEpgOnlineNews/~4/s9ytfLpsYSQ" height="1" width="1"/&gt;</description><feedburner:origLink>http://www.epgonline.org/news/2013/May/Seattle-Genetics-files-Adcetrisat.cfm</feedburner:origLink></item>

<item>
<title>FDA accepts BLA from Biogen for Eloctate for treatment of Haemophilia A</title>
<link>http://feedproxy.google.com/~r/LatestEpgOnlineNews/~3/HHpPVP9us10/FDA-accepts-BLA-fromBiogen.cfm</link>
<category>Haemophilia</category>
<pubDate>Wed, 15 May 2013 00:05:00 GMT</pubDate>
<description>&lt;div class="feedflare"&gt;
&lt;a href="http://feeds.feedburner.com/~ff/LatestEpgOnlineNews?a=HHpPVP9us10:ukDkDDpcR3E:yIl2AUoC8zA"&gt;&lt;img src="http://feeds.feedburner.com/~ff/LatestEpgOnlineNews?d=yIl2AUoC8zA" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/LatestEpgOnlineNews?a=HHpPVP9us10:ukDkDDpcR3E:V_sGLiPBpWU"&gt;&lt;img src="http://feeds.feedburner.com/~ff/LatestEpgOnlineNews?i=HHpPVP9us10:ukDkDDpcR3E:V_sGLiPBpWU" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/LatestEpgOnlineNews?a=HHpPVP9us10:ukDkDDpcR3E:qj6IDK7rITs"&gt;&lt;img src="http://feeds.feedburner.com/~ff/LatestEpgOnlineNews?d=qj6IDK7rITs" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/LatestEpgOnlineNews?a=HHpPVP9us10:ukDkDDpcR3E:gIN9vFwOqvQ"&gt;&lt;img src="http://feeds.feedburner.com/~ff/LatestEpgOnlineNews?i=HHpPVP9us10:ukDkDDpcR3E:gIN9vFwOqvQ" border="0"&gt;&lt;/img&gt;&lt;/a&gt;
&lt;/div&gt;&lt;img src="http://feeds.feedburner.com/~r/LatestEpgOnlineNews/~4/HHpPVP9us10" height="1" width="1"/&gt;</description><feedburner:origLink>http://www.epgonline.org/news/2013/May/FDA-accepts-BLA-fromBiogen.cfm</feedburner:origLink></item>

<item>
<title>FDA approves Nymalize (Arbor Pharmaceuticals) for Sub Arachnoid Haemorrhage</title>
<link>http://feedproxy.google.com/~r/LatestEpgOnlineNews/~3/JJ8EKvHSnRQ/FDA-approves-Nymalize-ArborPharmaceuticals-.cfm</link>
<category>Sub Arachnoid Haemorrhage</category>
<pubDate>Wed, 15 May 2013 00:05:00 GMT</pubDate>
<description>&lt;div class="feedflare"&gt;
&lt;a href="http://feeds.feedburner.com/~ff/LatestEpgOnlineNews?a=JJ8EKvHSnRQ:peGJp3YG8bU:yIl2AUoC8zA"&gt;&lt;img src="http://feeds.feedburner.com/~ff/LatestEpgOnlineNews?d=yIl2AUoC8zA" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/LatestEpgOnlineNews?a=JJ8EKvHSnRQ:peGJp3YG8bU:V_sGLiPBpWU"&gt;&lt;img src="http://feeds.feedburner.com/~ff/LatestEpgOnlineNews?i=JJ8EKvHSnRQ:peGJp3YG8bU:V_sGLiPBpWU" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/LatestEpgOnlineNews?a=JJ8EKvHSnRQ:peGJp3YG8bU:qj6IDK7rITs"&gt;&lt;img src="http://feeds.feedburner.com/~ff/LatestEpgOnlineNews?d=qj6IDK7rITs" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/LatestEpgOnlineNews?a=JJ8EKvHSnRQ:peGJp3YG8bU:gIN9vFwOqvQ"&gt;&lt;img src="http://feeds.feedburner.com/~ff/LatestEpgOnlineNews?i=JJ8EKvHSnRQ:peGJp3YG8bU:gIN9vFwOqvQ" border="0"&gt;&lt;/img&gt;&lt;/a&gt;
&lt;/div&gt;&lt;img src="http://feeds.feedburner.com/~r/LatestEpgOnlineNews/~4/JJ8EKvHSnRQ" height="1" width="1"/&gt;</description><feedburner:origLink>http://www.epgonline.org/news/2013/May/FDA-approves-Nymalize-ArborPharmaceuticals-.cfm</feedburner:origLink></item>

<item>
<title>Succesful Phase III studies with Fycompa (Eisai) for Epilepsy published in Epilepsia</title>
<link>http://feedproxy.google.com/~r/LatestEpgOnlineNews/~3/U_8U9vnqImQ/Succesful-Phase-III-studieswith.cfm</link>
<category>Epilepsy</category>
<pubDate>Tue, 14 May 2013 00:05:00 GMT</pubDate>
<description>&lt;div class="feedflare"&gt;
&lt;a href="http://feeds.feedburner.com/~ff/LatestEpgOnlineNews?a=U_8U9vnqImQ:Hm_MpJMIYRU:yIl2AUoC8zA"&gt;&lt;img src="http://feeds.feedburner.com/~ff/LatestEpgOnlineNews?d=yIl2AUoC8zA" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/LatestEpgOnlineNews?a=U_8U9vnqImQ:Hm_MpJMIYRU:V_sGLiPBpWU"&gt;&lt;img src="http://feeds.feedburner.com/~ff/LatestEpgOnlineNews?i=U_8U9vnqImQ:Hm_MpJMIYRU:V_sGLiPBpWU" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/LatestEpgOnlineNews?a=U_8U9vnqImQ:Hm_MpJMIYRU:qj6IDK7rITs"&gt;&lt;img src="http://feeds.feedburner.com/~ff/LatestEpgOnlineNews?d=qj6IDK7rITs" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/LatestEpgOnlineNews?a=U_8U9vnqImQ:Hm_MpJMIYRU:gIN9vFwOqvQ"&gt;&lt;img src="http://feeds.feedburner.com/~ff/LatestEpgOnlineNews?i=U_8U9vnqImQ:Hm_MpJMIYRU:gIN9vFwOqvQ" border="0"&gt;&lt;/img&gt;&lt;/a&gt;
&lt;/div&gt;&lt;img src="http://feeds.feedburner.com/~r/LatestEpgOnlineNews/~4/U_8U9vnqImQ" height="1" width="1"/&gt;</description><feedburner:origLink>http://www.epgonline.org/news/2013/May/Succesful-Phase-III-studieswith.cfm</feedburner:origLink></item>

<item>
<title>CE Mark granted for  Architectt HbA1c test to diagnose Diabetes</title>
<link>http://feedproxy.google.com/~r/LatestEpgOnlineNews/~3/SjEB50zVdj8/CE-Mark-granted-forArchitectt.cfm</link>
<category>Diabetes Types 1 &amp; 2</category>
<pubDate>Mon, 13 May 2013 00:05:00 GMT</pubDate>
<description>&lt;div class="feedflare"&gt;
&lt;a href="http://feeds.feedburner.com/~ff/LatestEpgOnlineNews?a=SjEB50zVdj8:Empsz8wBmwE:yIl2AUoC8zA"&gt;&lt;img src="http://feeds.feedburner.com/~ff/LatestEpgOnlineNews?d=yIl2AUoC8zA" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/LatestEpgOnlineNews?a=SjEB50zVdj8:Empsz8wBmwE:V_sGLiPBpWU"&gt;&lt;img src="http://feeds.feedburner.com/~ff/LatestEpgOnlineNews?i=SjEB50zVdj8:Empsz8wBmwE:V_sGLiPBpWU" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/LatestEpgOnlineNews?a=SjEB50zVdj8:Empsz8wBmwE:qj6IDK7rITs"&gt;&lt;img src="http://feeds.feedburner.com/~ff/LatestEpgOnlineNews?d=qj6IDK7rITs" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/LatestEpgOnlineNews?a=SjEB50zVdj8:Empsz8wBmwE:gIN9vFwOqvQ"&gt;&lt;img src="http://feeds.feedburner.com/~ff/LatestEpgOnlineNews?i=SjEB50zVdj8:Empsz8wBmwE:gIN9vFwOqvQ" border="0"&gt;&lt;/img&gt;&lt;/a&gt;
&lt;/div&gt;&lt;img src="http://feeds.feedburner.com/~r/LatestEpgOnlineNews/~4/SjEB50zVdj8" height="1" width="1"/&gt;</description><feedburner:origLink>http://www.epgonline.org/news/2013/May/CE-Mark-granted-forArchitectt.cfm</feedburner:origLink></item>

<item>
<title>Enzastaurin (Eli Lilly) fails Phase III trial for B Cell Lymphoma</title>
<link>http://feedproxy.google.com/~r/LatestEpgOnlineNews/~3/kY_DFc0U0xc/Enzastaurin-Eli-Lilly-failsPhase.cfm</link>
<category>B Cell Lymphoma (NHL)</category>
<pubDate>Sun, 12 May 2013 00:05:00 GMT</pubDate>
<description>&lt;div class="feedflare"&gt;
&lt;a href="http://feeds.feedburner.com/~ff/LatestEpgOnlineNews?a=kY_DFc0U0xc:lSTD9AB6DCg:yIl2AUoC8zA"&gt;&lt;img src="http://feeds.feedburner.com/~ff/LatestEpgOnlineNews?d=yIl2AUoC8zA" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/LatestEpgOnlineNews?a=kY_DFc0U0xc:lSTD9AB6DCg:V_sGLiPBpWU"&gt;&lt;img src="http://feeds.feedburner.com/~ff/LatestEpgOnlineNews?i=kY_DFc0U0xc:lSTD9AB6DCg:V_sGLiPBpWU" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/LatestEpgOnlineNews?a=kY_DFc0U0xc:lSTD9AB6DCg:qj6IDK7rITs"&gt;&lt;img src="http://feeds.feedburner.com/~ff/LatestEpgOnlineNews?d=qj6IDK7rITs" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/LatestEpgOnlineNews?a=kY_DFc0U0xc:lSTD9AB6DCg:gIN9vFwOqvQ"&gt;&lt;img src="http://feeds.feedburner.com/~ff/LatestEpgOnlineNews?i=kY_DFc0U0xc:lSTD9AB6DCg:gIN9vFwOqvQ" border="0"&gt;&lt;/img&gt;&lt;/a&gt;
&lt;/div&gt;&lt;img src="http://feeds.feedburner.com/~r/LatestEpgOnlineNews/~4/kY_DFc0U0xc" height="1" width="1"/&gt;</description><feedburner:origLink>http://www.epgonline.org/news/2013/May/Enzastaurin-Eli-Lilly-failsPhase.cfm</feedburner:origLink></item>

<item>
<title>FDA approves Ilaris (Novartis) for treatment of Systemic Juvenile Idiopathic Arthritis</title>
<link>http://feedproxy.google.com/~r/LatestEpgOnlineNews/~3/A1n8mWnmekw/FDA-approves-Ilaris-Novartis-for.cfm</link>
<category>Juvenile Idiopathic Arthritis</category>
<pubDate>Sat, 11 May 2013 00:05:00 GMT</pubDate>
<description>&lt;div class="feedflare"&gt;
&lt;a href="http://feeds.feedburner.com/~ff/LatestEpgOnlineNews?a=A1n8mWnmekw:vrVE9Uazlq4:yIl2AUoC8zA"&gt;&lt;img src="http://feeds.feedburner.com/~ff/LatestEpgOnlineNews?d=yIl2AUoC8zA" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/LatestEpgOnlineNews?a=A1n8mWnmekw:vrVE9Uazlq4:V_sGLiPBpWU"&gt;&lt;img src="http://feeds.feedburner.com/~ff/LatestEpgOnlineNews?i=A1n8mWnmekw:vrVE9Uazlq4:V_sGLiPBpWU" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/LatestEpgOnlineNews?a=A1n8mWnmekw:vrVE9Uazlq4:qj6IDK7rITs"&gt;&lt;img src="http://feeds.feedburner.com/~ff/LatestEpgOnlineNews?d=qj6IDK7rITs" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/LatestEpgOnlineNews?a=A1n8mWnmekw:vrVE9Uazlq4:gIN9vFwOqvQ"&gt;&lt;img src="http://feeds.feedburner.com/~ff/LatestEpgOnlineNews?i=A1n8mWnmekw:vrVE9Uazlq4:gIN9vFwOqvQ" border="0"&gt;&lt;/img&gt;&lt;/a&gt;
&lt;/div&gt;&lt;img src="http://feeds.feedburner.com/~r/LatestEpgOnlineNews/~4/A1n8mWnmekw" height="1" width="1"/&gt;</description><feedburner:origLink>http://www.epgonline.org/news/2013/May/FDA-approves-Ilaris-Novartis-for.cfm</feedburner:origLink></item>

<item>
<title>Two analyses show Fycompa (Eisai) effective for Epilepsy</title>
<link>http://feedproxy.google.com/~r/LatestEpgOnlineNews/~3/2ty6Zwa17QM/Two-analyses-show-Fycompa-Eisai-.cfm</link>
<category>Epilepsy</category>
<pubDate>Sat, 11 May 2013 00:05:00 GMT</pubDate>
<description>&lt;div class="feedflare"&gt;
&lt;a href="http://feeds.feedburner.com/~ff/LatestEpgOnlineNews?a=2ty6Zwa17QM:3FmE_Ns00rU:yIl2AUoC8zA"&gt;&lt;img src="http://feeds.feedburner.com/~ff/LatestEpgOnlineNews?d=yIl2AUoC8zA" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/LatestEpgOnlineNews?a=2ty6Zwa17QM:3FmE_Ns00rU:V_sGLiPBpWU"&gt;&lt;img src="http://feeds.feedburner.com/~ff/LatestEpgOnlineNews?i=2ty6Zwa17QM:3FmE_Ns00rU:V_sGLiPBpWU" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/LatestEpgOnlineNews?a=2ty6Zwa17QM:3FmE_Ns00rU:qj6IDK7rITs"&gt;&lt;img src="http://feeds.feedburner.com/~ff/LatestEpgOnlineNews?d=qj6IDK7rITs" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/LatestEpgOnlineNews?a=2ty6Zwa17QM:3FmE_Ns00rU:gIN9vFwOqvQ"&gt;&lt;img src="http://feeds.feedburner.com/~ff/LatestEpgOnlineNews?i=2ty6Zwa17QM:3FmE_Ns00rU:gIN9vFwOqvQ" border="0"&gt;&lt;/img&gt;&lt;/a&gt;
&lt;/div&gt;&lt;img src="http://feeds.feedburner.com/~r/LatestEpgOnlineNews/~4/2ty6Zwa17QM" height="1" width="1"/&gt;</description><feedburner:origLink>http://www.epgonline.org/news/2013/May/Two-analyses-show-Fycompa-Eisai-.cfm</feedburner:origLink></item>

<item>
<title>PROTECT-AF trial of Watchman LAAC (Boston Scientific) successful for Stroke Prevention</title>
<link>http://feedproxy.google.com/~r/LatestEpgOnlineNews/~3/7Vg0rZuRn54/PROTECT-AF-trial-of-WatchmanLAAC.cfm</link>
<category>Stroke Prevention (AF)</category>
<pubDate>Sat, 11 May 2013 00:05:00 GMT</pubDate>
<description>&lt;div class="feedflare"&gt;
&lt;a href="http://feeds.feedburner.com/~ff/LatestEpgOnlineNews?a=7Vg0rZuRn54:33fPf4eJm4o:yIl2AUoC8zA"&gt;&lt;img src="http://feeds.feedburner.com/~ff/LatestEpgOnlineNews?d=yIl2AUoC8zA" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/LatestEpgOnlineNews?a=7Vg0rZuRn54:33fPf4eJm4o:V_sGLiPBpWU"&gt;&lt;img src="http://feeds.feedburner.com/~ff/LatestEpgOnlineNews?i=7Vg0rZuRn54:33fPf4eJm4o:V_sGLiPBpWU" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/LatestEpgOnlineNews?a=7Vg0rZuRn54:33fPf4eJm4o:qj6IDK7rITs"&gt;&lt;img src="http://feeds.feedburner.com/~ff/LatestEpgOnlineNews?d=qj6IDK7rITs" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/LatestEpgOnlineNews?a=7Vg0rZuRn54:33fPf4eJm4o:gIN9vFwOqvQ"&gt;&lt;img src="http://feeds.feedburner.com/~ff/LatestEpgOnlineNews?i=7Vg0rZuRn54:33fPf4eJm4o:gIN9vFwOqvQ" border="0"&gt;&lt;/img&gt;&lt;/a&gt;
&lt;/div&gt;&lt;img src="http://feeds.feedburner.com/~r/LatestEpgOnlineNews/~4/7Vg0rZuRn54" height="1" width="1"/&gt;</description><feedburner:origLink>http://www.epgonline.org/news/2013/May/PROTECT-AF-trial-of-WatchmanLAAC.cfm</feedburner:origLink></item>

<item>
<title>Merck Inc files MK 3641 at FDA for treatment of Ragweed Pollen Allergies</title>
<link>http://feedproxy.google.com/~r/LatestEpgOnlineNews/~3/R9QnvLWbB2I/Merck-Inc-files-MK3641.cfm</link>
<category>Allergy/Ragweed</category>
<pubDate>Fri, 10 May 2013 00:05:00 GMT</pubDate>
<description>&lt;div class="feedflare"&gt;
&lt;a href="http://feeds.feedburner.com/~ff/LatestEpgOnlineNews?a=R9QnvLWbB2I:NnsoS043vFw:yIl2AUoC8zA"&gt;&lt;img src="http://feeds.feedburner.com/~ff/LatestEpgOnlineNews?d=yIl2AUoC8zA" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/LatestEpgOnlineNews?a=R9QnvLWbB2I:NnsoS043vFw:V_sGLiPBpWU"&gt;&lt;img src="http://feeds.feedburner.com/~ff/LatestEpgOnlineNews?i=R9QnvLWbB2I:NnsoS043vFw:V_sGLiPBpWU" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/LatestEpgOnlineNews?a=R9QnvLWbB2I:NnsoS043vFw:qj6IDK7rITs"&gt;&lt;img src="http://feeds.feedburner.com/~ff/LatestEpgOnlineNews?d=qj6IDK7rITs" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/LatestEpgOnlineNews?a=R9QnvLWbB2I:NnsoS043vFw:gIN9vFwOqvQ"&gt;&lt;img src="http://feeds.feedburner.com/~ff/LatestEpgOnlineNews?i=R9QnvLWbB2I:NnsoS043vFw:gIN9vFwOqvQ" border="0"&gt;&lt;/img&gt;&lt;/a&gt;
&lt;/div&gt;&lt;img src="http://feeds.feedburner.com/~r/LatestEpgOnlineNews/~4/R9QnvLWbB2I" height="1" width="1"/&gt;</description><feedburner:origLink>http://www.epgonline.org/news/2013/May/Merck-Inc-files-MK3641.cfm</feedburner:origLink></item>

<item>
<title>Trial shows Vascazen (Pivotal Therapeutics) effective in altering cholesterol levels in patients with CV Risk</title>
<link>http://feedproxy.google.com/~r/LatestEpgOnlineNews/~3/MjO01rtYSHE/Trial-shows-Vascazen-PivotalTherapeutics-.cfm</link>
<category>Nutrition/CV Risk</category>
<pubDate>Fri, 10 May 2013 00:05:00 GMT</pubDate>
<description>&lt;div class="feedflare"&gt;
&lt;a href="http://feeds.feedburner.com/~ff/LatestEpgOnlineNews?a=MjO01rtYSHE:2HFHZVj-cGQ:yIl2AUoC8zA"&gt;&lt;img src="http://feeds.feedburner.com/~ff/LatestEpgOnlineNews?d=yIl2AUoC8zA" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/LatestEpgOnlineNews?a=MjO01rtYSHE:2HFHZVj-cGQ:V_sGLiPBpWU"&gt;&lt;img src="http://feeds.feedburner.com/~ff/LatestEpgOnlineNews?i=MjO01rtYSHE:2HFHZVj-cGQ:V_sGLiPBpWU" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/LatestEpgOnlineNews?a=MjO01rtYSHE:2HFHZVj-cGQ:qj6IDK7rITs"&gt;&lt;img src="http://feeds.feedburner.com/~ff/LatestEpgOnlineNews?d=qj6IDK7rITs" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/LatestEpgOnlineNews?a=MjO01rtYSHE:2HFHZVj-cGQ:gIN9vFwOqvQ"&gt;&lt;img src="http://feeds.feedburner.com/~ff/LatestEpgOnlineNews?i=MjO01rtYSHE:2HFHZVj-cGQ:gIN9vFwOqvQ" border="0"&gt;&lt;/img&gt;&lt;/a&gt;
&lt;/div&gt;&lt;img src="http://feeds.feedburner.com/~r/LatestEpgOnlineNews/~4/MjO01rtYSHE" height="1" width="1"/&gt;</description><feedburner:origLink>http://www.epgonline.org/news/2013/May/Trial-shows-Vascazen-PivotalTherapeutics-.cfm</feedburner:origLink></item>

<item>
<title>FDA approves Ilesto 7 ICD/CRT-D (Biotronik) for patients with Heart Failure</title>
<link>http://feedproxy.google.com/~r/LatestEpgOnlineNews/~3/HAsmAwB_8To/FDA-approves-Ilesto-7ICD-CRT-D.cfm</link>
<category>Atrial Fibrillation in Heart Failure</category>
<pubDate>Fri, 10 May 2013 00:05:00 GMT</pubDate>
<description>&lt;div class="feedflare"&gt;
&lt;a href="http://feeds.feedburner.com/~ff/LatestEpgOnlineNews?a=HAsmAwB_8To:0rhK-eaK5sI:yIl2AUoC8zA"&gt;&lt;img src="http://feeds.feedburner.com/~ff/LatestEpgOnlineNews?d=yIl2AUoC8zA" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/LatestEpgOnlineNews?a=HAsmAwB_8To:0rhK-eaK5sI:V_sGLiPBpWU"&gt;&lt;img src="http://feeds.feedburner.com/~ff/LatestEpgOnlineNews?i=HAsmAwB_8To:0rhK-eaK5sI:V_sGLiPBpWU" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/LatestEpgOnlineNews?a=HAsmAwB_8To:0rhK-eaK5sI:qj6IDK7rITs"&gt;&lt;img src="http://feeds.feedburner.com/~ff/LatestEpgOnlineNews?d=qj6IDK7rITs" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/LatestEpgOnlineNews?a=HAsmAwB_8To:0rhK-eaK5sI:gIN9vFwOqvQ"&gt;&lt;img src="http://feeds.feedburner.com/~ff/LatestEpgOnlineNews?i=HAsmAwB_8To:0rhK-eaK5sI:gIN9vFwOqvQ" border="0"&gt;&lt;/img&gt;&lt;/a&gt;
&lt;/div&gt;&lt;img src="http://feeds.feedburner.com/~r/LatestEpgOnlineNews/~4/HAsmAwB_8To" height="1" width="1"/&gt;</description><feedburner:origLink>http://www.epgonline.org/news/2013/May/FDA-approves-Ilesto-7ICD-CRT-D.cfm</feedburner:origLink></item>

<item>
<title>Teva Pharmaceutical Industries will market Adasuve for  treatment of agitation in Schizophrenia in the United States</title>
<link>http://feedproxy.google.com/~r/LatestEpgOnlineNews/~3/Ip9NPkY43pU/Teva-Pharmaceutical-Industries-willmarket.cfm</link>
<category>Schizophrenia</category>
<pubDate>Fri, 10 May 2013 00:05:00 GMT</pubDate>
<description>&lt;div class="feedflare"&gt;
&lt;a href="http://feeds.feedburner.com/~ff/LatestEpgOnlineNews?a=Ip9NPkY43pU:jf9M6AOpDCo:yIl2AUoC8zA"&gt;&lt;img src="http://feeds.feedburner.com/~ff/LatestEpgOnlineNews?d=yIl2AUoC8zA" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/LatestEpgOnlineNews?a=Ip9NPkY43pU:jf9M6AOpDCo:V_sGLiPBpWU"&gt;&lt;img src="http://feeds.feedburner.com/~ff/LatestEpgOnlineNews?i=Ip9NPkY43pU:jf9M6AOpDCo:V_sGLiPBpWU" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/LatestEpgOnlineNews?a=Ip9NPkY43pU:jf9M6AOpDCo:qj6IDK7rITs"&gt;&lt;img src="http://feeds.feedburner.com/~ff/LatestEpgOnlineNews?d=qj6IDK7rITs" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/LatestEpgOnlineNews?a=Ip9NPkY43pU:jf9M6AOpDCo:gIN9vFwOqvQ"&gt;&lt;img src="http://feeds.feedburner.com/~ff/LatestEpgOnlineNews?i=Ip9NPkY43pU:jf9M6AOpDCo:gIN9vFwOqvQ" border="0"&gt;&lt;/img&gt;&lt;/a&gt;
&lt;/div&gt;&lt;img src="http://feeds.feedburner.com/~r/LatestEpgOnlineNews/~4/Ip9NPkY43pU" height="1" width="1"/&gt;</description><feedburner:origLink>http://www.epgonline.org/news/2013/May/Teva-Pharmaceutical-Industries-willmarket.cfm</feedburner:origLink></item>

<item>
<title>EU approves Octava Pink test (Eventus Diagnostics) for detecting Breast Cancer</title>
<link>http://feedproxy.google.com/~r/LatestEpgOnlineNews/~3/kes1MDEgNDY/EU-approves-Octava-Pinktest.cfm</link>
<category>Breast Cancer</category>
<pubDate>Fri, 10 May 2013 00:05:00 GMT</pubDate>
<description>&lt;div class="feedflare"&gt;
&lt;a href="http://feeds.feedburner.com/~ff/LatestEpgOnlineNews?a=kes1MDEgNDY:xB734DO6Ygo:yIl2AUoC8zA"&gt;&lt;img src="http://feeds.feedburner.com/~ff/LatestEpgOnlineNews?d=yIl2AUoC8zA" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/LatestEpgOnlineNews?a=kes1MDEgNDY:xB734DO6Ygo:V_sGLiPBpWU"&gt;&lt;img src="http://feeds.feedburner.com/~ff/LatestEpgOnlineNews?i=kes1MDEgNDY:xB734DO6Ygo:V_sGLiPBpWU" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/LatestEpgOnlineNews?a=kes1MDEgNDY:xB734DO6Ygo:qj6IDK7rITs"&gt;&lt;img src="http://feeds.feedburner.com/~ff/LatestEpgOnlineNews?d=qj6IDK7rITs" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/LatestEpgOnlineNews?a=kes1MDEgNDY:xB734DO6Ygo:gIN9vFwOqvQ"&gt;&lt;img src="http://feeds.feedburner.com/~ff/LatestEpgOnlineNews?i=kes1MDEgNDY:xB734DO6Ygo:gIN9vFwOqvQ" border="0"&gt;&lt;/img&gt;&lt;/a&gt;
&lt;/div&gt;&lt;img src="http://feeds.feedburner.com/~r/LatestEpgOnlineNews/~4/kes1MDEgNDY" height="1" width="1"/&gt;</description><feedburner:origLink>http://www.epgonline.org/news/2013/May/EU-approves-Octava-Pinktest.cfm</feedburner:origLink></item>

<item>
<title>ASPECCT study of Vectibix (Amgen) compared to Erbitux in treatment of Colorectal Cancer</title>
<link>http://feedproxy.google.com/~r/LatestEpgOnlineNews/~3/8Uo7Hq9mctk/ASPECCT-study-of-Vectibix-Amgen-.cfm</link>
<category>Colorectal Cancer</category>
<pubDate>Thu, 09 May 2013 00:05:00 GMT</pubDate>
<description>&lt;div class="feedflare"&gt;
&lt;a href="http://feeds.feedburner.com/~ff/LatestEpgOnlineNews?a=8Uo7Hq9mctk:BvaJb9vqEtc:yIl2AUoC8zA"&gt;&lt;img src="http://feeds.feedburner.com/~ff/LatestEpgOnlineNews?d=yIl2AUoC8zA" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/LatestEpgOnlineNews?a=8Uo7Hq9mctk:BvaJb9vqEtc:V_sGLiPBpWU"&gt;&lt;img src="http://feeds.feedburner.com/~ff/LatestEpgOnlineNews?i=8Uo7Hq9mctk:BvaJb9vqEtc:V_sGLiPBpWU" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/LatestEpgOnlineNews?a=8Uo7Hq9mctk:BvaJb9vqEtc:qj6IDK7rITs"&gt;&lt;img src="http://feeds.feedburner.com/~ff/LatestEpgOnlineNews?d=qj6IDK7rITs" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/LatestEpgOnlineNews?a=8Uo7Hq9mctk:BvaJb9vqEtc:gIN9vFwOqvQ"&gt;&lt;img src="http://feeds.feedburner.com/~ff/LatestEpgOnlineNews?i=8Uo7Hq9mctk:BvaJb9vqEtc:gIN9vFwOqvQ" border="0"&gt;&lt;/img&gt;&lt;/a&gt;
&lt;/div&gt;&lt;img src="http://feeds.feedburner.com/~r/LatestEpgOnlineNews/~4/8Uo7Hq9mctk" height="1" width="1"/&gt;</description><feedburner:origLink>http://www.epgonline.org/news/2013/May/ASPECCT-study-of-Vectibix-Amgen-.cfm</feedburner:origLink></item>

<item>
<title>PALACE 4 study confirms success of apremilast (Celgene) in treatment of Psoriaric Arthritis</title>
<link>http://feedproxy.google.com/~r/LatestEpgOnlineNews/~3/iJFQbQRgq80/PALACE-4-study-confirmssuccess.cfm</link>
<category>Psoriatic Arthritis</category>
<pubDate>Wed, 08 May 2013 00:05:00 GMT</pubDate>
<description>&lt;div class="feedflare"&gt;
&lt;a href="http://feeds.feedburner.com/~ff/LatestEpgOnlineNews?a=iJFQbQRgq80:iTmekQvX0rc:yIl2AUoC8zA"&gt;&lt;img src="http://feeds.feedburner.com/~ff/LatestEpgOnlineNews?d=yIl2AUoC8zA" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/LatestEpgOnlineNews?a=iJFQbQRgq80:iTmekQvX0rc:V_sGLiPBpWU"&gt;&lt;img src="http://feeds.feedburner.com/~ff/LatestEpgOnlineNews?i=iJFQbQRgq80:iTmekQvX0rc:V_sGLiPBpWU" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/LatestEpgOnlineNews?a=iJFQbQRgq80:iTmekQvX0rc:qj6IDK7rITs"&gt;&lt;img src="http://feeds.feedburner.com/~ff/LatestEpgOnlineNews?d=qj6IDK7rITs" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/LatestEpgOnlineNews?a=iJFQbQRgq80:iTmekQvX0rc:gIN9vFwOqvQ"&gt;&lt;img src="http://feeds.feedburner.com/~ff/LatestEpgOnlineNews?i=iJFQbQRgq80:iTmekQvX0rc:gIN9vFwOqvQ" border="0"&gt;&lt;/img&gt;&lt;/a&gt;
&lt;/div&gt;&lt;img src="http://feeds.feedburner.com/~r/LatestEpgOnlineNews/~4/iJFQbQRgq80" height="1" width="1"/&gt;</description><feedburner:origLink>http://www.epgonline.org/news/2013/May/PALACE-4-study-confirmssuccess.cfm</feedburner:origLink></item>

<item>
<title>Metreleptin sub analysis in paediatric patients with Lipodystrophy</title>
<link>http://feedproxy.google.com/~r/LatestEpgOnlineNews/~3/44N2qui7R1Q/Metreleptin-sub-analysis-inpaediatric.cfm</link>
<category>Lipodystrophy</category>
<pubDate>Wed, 08 May 2013 00:05:00 GMT</pubDate>
<description>&lt;div class="feedflare"&gt;
&lt;a href="http://feeds.feedburner.com/~ff/LatestEpgOnlineNews?a=44N2qui7R1Q:33DuCGtIgqI:yIl2AUoC8zA"&gt;&lt;img src="http://feeds.feedburner.com/~ff/LatestEpgOnlineNews?d=yIl2AUoC8zA" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/LatestEpgOnlineNews?a=44N2qui7R1Q:33DuCGtIgqI:V_sGLiPBpWU"&gt;&lt;img src="http://feeds.feedburner.com/~ff/LatestEpgOnlineNews?i=44N2qui7R1Q:33DuCGtIgqI:V_sGLiPBpWU" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/LatestEpgOnlineNews?a=44N2qui7R1Q:33DuCGtIgqI:qj6IDK7rITs"&gt;&lt;img src="http://feeds.feedburner.com/~ff/LatestEpgOnlineNews?d=qj6IDK7rITs" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/LatestEpgOnlineNews?a=44N2qui7R1Q:33DuCGtIgqI:gIN9vFwOqvQ"&gt;&lt;img src="http://feeds.feedburner.com/~ff/LatestEpgOnlineNews?i=44N2qui7R1Q:33DuCGtIgqI:gIN9vFwOqvQ" border="0"&gt;&lt;/img&gt;&lt;/a&gt;
&lt;/div&gt;&lt;img src="http://feeds.feedburner.com/~r/LatestEpgOnlineNews/~4/44N2qui7R1Q" height="1" width="1"/&gt;</description><feedburner:origLink>http://www.epgonline.org/news/2013/May/Metreleptin-sub-analysis-inpaediatric.cfm</feedburner:origLink></item>

<item>
<title>FDA approves Viva and Evera defibrillators for Heart Failure</title>
<link>http://feedproxy.google.com/~r/LatestEpgOnlineNews/~3/2QmDYNlu0bE/FDA-approves-Viva-andEvera.cfm</link>
<category>Heart Failure</category>
<pubDate>Wed, 08 May 2013 00:05:00 GMT</pubDate>
<description>&lt;div class="feedflare"&gt;
&lt;a href="http://feeds.feedburner.com/~ff/LatestEpgOnlineNews?a=2QmDYNlu0bE:_H0i_hzP7FA:yIl2AUoC8zA"&gt;&lt;img src="http://feeds.feedburner.com/~ff/LatestEpgOnlineNews?d=yIl2AUoC8zA" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/LatestEpgOnlineNews?a=2QmDYNlu0bE:_H0i_hzP7FA:V_sGLiPBpWU"&gt;&lt;img src="http://feeds.feedburner.com/~ff/LatestEpgOnlineNews?i=2QmDYNlu0bE:_H0i_hzP7FA:V_sGLiPBpWU" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/LatestEpgOnlineNews?a=2QmDYNlu0bE:_H0i_hzP7FA:qj6IDK7rITs"&gt;&lt;img src="http://feeds.feedburner.com/~ff/LatestEpgOnlineNews?d=qj6IDK7rITs" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/LatestEpgOnlineNews?a=2QmDYNlu0bE:_H0i_hzP7FA:gIN9vFwOqvQ"&gt;&lt;img src="http://feeds.feedburner.com/~ff/LatestEpgOnlineNews?i=2QmDYNlu0bE:_H0i_hzP7FA:gIN9vFwOqvQ" border="0"&gt;&lt;/img&gt;&lt;/a&gt;
&lt;/div&gt;&lt;img src="http://feeds.feedburner.com/~r/LatestEpgOnlineNews/~4/2QmDYNlu0bE" height="1" width="1"/&gt;</description><feedburner:origLink>http://www.epgonline.org/news/2013/May/FDA-approves-Viva-andEvera.cfm</feedburner:origLink></item>

<item>
<title>Immunoglobulin (Baxter)  fails Phase III study for treatment of Alzheimers disease</title>
<link>http://feedproxy.google.com/~r/LatestEpgOnlineNews/~3/N-JW_y6RK0A/Immunoglobulin-Baxter-fails-PhaseIII.cfm</link>
<category>Alzheimers</category>
<pubDate>Wed, 08 May 2013 00:05:00 GMT</pubDate>
<description>&lt;div class="feedflare"&gt;
&lt;a href="http://feeds.feedburner.com/~ff/LatestEpgOnlineNews?a=N-JW_y6RK0A:saONpfmKhFU:yIl2AUoC8zA"&gt;&lt;img src="http://feeds.feedburner.com/~ff/LatestEpgOnlineNews?d=yIl2AUoC8zA" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/LatestEpgOnlineNews?a=N-JW_y6RK0A:saONpfmKhFU:V_sGLiPBpWU"&gt;&lt;img src="http://feeds.feedburner.com/~ff/LatestEpgOnlineNews?i=N-JW_y6RK0A:saONpfmKhFU:V_sGLiPBpWU" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/LatestEpgOnlineNews?a=N-JW_y6RK0A:saONpfmKhFU:qj6IDK7rITs"&gt;&lt;img src="http://feeds.feedburner.com/~ff/LatestEpgOnlineNews?d=qj6IDK7rITs" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/LatestEpgOnlineNews?a=N-JW_y6RK0A:saONpfmKhFU:gIN9vFwOqvQ"&gt;&lt;img src="http://feeds.feedburner.com/~ff/LatestEpgOnlineNews?i=N-JW_y6RK0A:saONpfmKhFU:gIN9vFwOqvQ" border="0"&gt;&lt;/img&gt;&lt;/a&gt;
&lt;/div&gt;&lt;img src="http://feeds.feedburner.com/~r/LatestEpgOnlineNews/~4/N-JW_y6RK0A" height="1" width="1"/&gt;</description><feedburner:origLink>http://www.epgonline.org/news/2013/May/Immunoglobulin-Baxter-fails-PhaseIII.cfm</feedburner:origLink></item>

<item>
<title>Four year follow up on EVEREST II study of Mitra Clip (Abbott)</title>
<link>http://feedproxy.google.com/~r/LatestEpgOnlineNews/~3/s-UHF2-TU_8/Four-year-follow-upon.cfm</link>
<category>Cardiac Surgery</category>
<pubDate>Wed, 08 May 2013 00:05:00 GMT</pubDate>
<description>&lt;div class="feedflare"&gt;
&lt;a href="http://feeds.feedburner.com/~ff/LatestEpgOnlineNews?a=s-UHF2-TU_8:OKhDIHtBk7Q:yIl2AUoC8zA"&gt;&lt;img src="http://feeds.feedburner.com/~ff/LatestEpgOnlineNews?d=yIl2AUoC8zA" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/LatestEpgOnlineNews?a=s-UHF2-TU_8:OKhDIHtBk7Q:V_sGLiPBpWU"&gt;&lt;img src="http://feeds.feedburner.com/~ff/LatestEpgOnlineNews?i=s-UHF2-TU_8:OKhDIHtBk7Q:V_sGLiPBpWU" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/LatestEpgOnlineNews?a=s-UHF2-TU_8:OKhDIHtBk7Q:qj6IDK7rITs"&gt;&lt;img src="http://feeds.feedburner.com/~ff/LatestEpgOnlineNews?d=qj6IDK7rITs" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/LatestEpgOnlineNews?a=s-UHF2-TU_8:OKhDIHtBk7Q:gIN9vFwOqvQ"&gt;&lt;img src="http://feeds.feedburner.com/~ff/LatestEpgOnlineNews?i=s-UHF2-TU_8:OKhDIHtBk7Q:gIN9vFwOqvQ" border="0"&gt;&lt;/img&gt;&lt;/a&gt;
&lt;/div&gt;&lt;img src="http://feeds.feedburner.com/~r/LatestEpgOnlineNews/~4/s-UHF2-TU_8" height="1" width="1"/&gt;</description><feedburner:origLink>http://www.epgonline.org/news/2013/May/Four-year-follow-upon.cfm</feedburner:origLink></item>

<item>
<title>Phase III trial shows FloraGlo lutein (OmniActive Health Technologies) fails to protect against AMD</title>
<link>http://feedproxy.google.com/~r/LatestEpgOnlineNews/~3/dLt-dR1VQhA/Phase-III-trial-showsFloraGlo.cfm</link>
<category>Nutrition/Eye Health</category>
<pubDate>Tue, 07 May 2013 00:05:00 GMT</pubDate>
<description>&lt;div class="feedflare"&gt;
&lt;a href="http://feeds.feedburner.com/~ff/LatestEpgOnlineNews?a=dLt-dR1VQhA:YNJR9JXaj84:yIl2AUoC8zA"&gt;&lt;img src="http://feeds.feedburner.com/~ff/LatestEpgOnlineNews?d=yIl2AUoC8zA" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/LatestEpgOnlineNews?a=dLt-dR1VQhA:YNJR9JXaj84:V_sGLiPBpWU"&gt;&lt;img src="http://feeds.feedburner.com/~ff/LatestEpgOnlineNews?i=dLt-dR1VQhA:YNJR9JXaj84:V_sGLiPBpWU" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/LatestEpgOnlineNews?a=dLt-dR1VQhA:YNJR9JXaj84:qj6IDK7rITs"&gt;&lt;img src="http://feeds.feedburner.com/~ff/LatestEpgOnlineNews?d=qj6IDK7rITs" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/LatestEpgOnlineNews?a=dLt-dR1VQhA:YNJR9JXaj84:gIN9vFwOqvQ"&gt;&lt;img src="http://feeds.feedburner.com/~ff/LatestEpgOnlineNews?i=dLt-dR1VQhA:YNJR9JXaj84:gIN9vFwOqvQ" border="0"&gt;&lt;/img&gt;&lt;/a&gt;
&lt;/div&gt;&lt;img src="http://feeds.feedburner.com/~r/LatestEpgOnlineNews/~4/dLt-dR1VQhA" height="1" width="1"/&gt;</description><feedburner:origLink>http://www.epgonline.org/news/2013/May/Phase-III-trial-showsFloraGlo.cfm</feedburner:origLink></item>

<item>
<title>FDA approves Liptruzet (Merck Inc) for Dyslipidaemia</title>
<link>http://feedproxy.google.com/~r/LatestEpgOnlineNews/~3/RaYAeGO70Qw/FDA-approves-Liptruzet-MerckInc-.cfm</link>
<category>Dyslipidaemia</category>
<pubDate>Tue, 07 May 2013 00:05:00 GMT</pubDate>
<description>&lt;div class="feedflare"&gt;
&lt;a href="http://feeds.feedburner.com/~ff/LatestEpgOnlineNews?a=RaYAeGO70Qw:0IlE_zR9n1s:yIl2AUoC8zA"&gt;&lt;img src="http://feeds.feedburner.com/~ff/LatestEpgOnlineNews?d=yIl2AUoC8zA" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/LatestEpgOnlineNews?a=RaYAeGO70Qw:0IlE_zR9n1s:V_sGLiPBpWU"&gt;&lt;img src="http://feeds.feedburner.com/~ff/LatestEpgOnlineNews?i=RaYAeGO70Qw:0IlE_zR9n1s:V_sGLiPBpWU" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/LatestEpgOnlineNews?a=RaYAeGO70Qw:0IlE_zR9n1s:qj6IDK7rITs"&gt;&lt;img src="http://feeds.feedburner.com/~ff/LatestEpgOnlineNews?d=qj6IDK7rITs" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/LatestEpgOnlineNews?a=RaYAeGO70Qw:0IlE_zR9n1s:gIN9vFwOqvQ"&gt;&lt;img src="http://feeds.feedburner.com/~ff/LatestEpgOnlineNews?i=RaYAeGO70Qw:0IlE_zR9n1s:gIN9vFwOqvQ" border="0"&gt;&lt;/img&gt;&lt;/a&gt;
&lt;/div&gt;&lt;img src="http://feeds.feedburner.com/~r/LatestEpgOnlineNews/~4/RaYAeGO70Qw" height="1" width="1"/&gt;</description><feedburner:origLink>http://www.epgonline.org/news/2013/May/FDA-approves-Liptruzet-MerckInc-.cfm</feedburner:origLink></item>

<item>
<title>FDA Advisory Committee rejects Melblez Kit (Delcath) for Ocular melanioma metastatic to the Liver</title>
<link>http://feedproxy.google.com/~r/LatestEpgOnlineNews/~3/oTLE2xKh1u8/FDA-Advisory-Committee-rejectsMelblez.cfm</link>
<category>Ocular melanoma metastatic to the Liver</category>
<pubDate>Mon, 06 May 2013 00:05:00 GMT</pubDate>
<description>&lt;div class="feedflare"&gt;
&lt;a href="http://feeds.feedburner.com/~ff/LatestEpgOnlineNews?a=oTLE2xKh1u8:Fm3-lVSGmH8:yIl2AUoC8zA"&gt;&lt;img src="http://feeds.feedburner.com/~ff/LatestEpgOnlineNews?d=yIl2AUoC8zA" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/LatestEpgOnlineNews?a=oTLE2xKh1u8:Fm3-lVSGmH8:V_sGLiPBpWU"&gt;&lt;img src="http://feeds.feedburner.com/~ff/LatestEpgOnlineNews?i=oTLE2xKh1u8:Fm3-lVSGmH8:V_sGLiPBpWU" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/LatestEpgOnlineNews?a=oTLE2xKh1u8:Fm3-lVSGmH8:qj6IDK7rITs"&gt;&lt;img src="http://feeds.feedburner.com/~ff/LatestEpgOnlineNews?d=qj6IDK7rITs" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/LatestEpgOnlineNews?a=oTLE2xKh1u8:Fm3-lVSGmH8:gIN9vFwOqvQ"&gt;&lt;img src="http://feeds.feedburner.com/~ff/LatestEpgOnlineNews?i=oTLE2xKh1u8:Fm3-lVSGmH8:gIN9vFwOqvQ" border="0"&gt;&lt;/img&gt;&lt;/a&gt;
&lt;/div&gt;&lt;img src="http://feeds.feedburner.com/~r/LatestEpgOnlineNews/~4/oTLE2xKh1u8" height="1" width="1"/&gt;</description><feedburner:origLink>http://www.epgonline.org/news/2013/May/FDA-Advisory-Committee-rejectsMelblez.cfm</feedburner:origLink></item>

<item>
<title>Early prediction of  Epileptic seizures study from NeuroVista</title>
<link>http://feedproxy.google.com/~r/LatestEpgOnlineNews/~3/9MKuHHfYBgk/Early-prediction-of-Epilepticseizures.cfm</link>
<category>Epilepsy</category>
<pubDate>Mon, 06 May 2013 00:05:00 GMT</pubDate>
<description>&lt;div class="feedflare"&gt;
&lt;a href="http://feeds.feedburner.com/~ff/LatestEpgOnlineNews?a=9MKuHHfYBgk:RbA3285iGCs:yIl2AUoC8zA"&gt;&lt;img src="http://feeds.feedburner.com/~ff/LatestEpgOnlineNews?d=yIl2AUoC8zA" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/LatestEpgOnlineNews?a=9MKuHHfYBgk:RbA3285iGCs:V_sGLiPBpWU"&gt;&lt;img src="http://feeds.feedburner.com/~ff/LatestEpgOnlineNews?i=9MKuHHfYBgk:RbA3285iGCs:V_sGLiPBpWU" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/LatestEpgOnlineNews?a=9MKuHHfYBgk:RbA3285iGCs:qj6IDK7rITs"&gt;&lt;img src="http://feeds.feedburner.com/~ff/LatestEpgOnlineNews?d=qj6IDK7rITs" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/LatestEpgOnlineNews?a=9MKuHHfYBgk:RbA3285iGCs:gIN9vFwOqvQ"&gt;&lt;img src="http://feeds.feedburner.com/~ff/LatestEpgOnlineNews?i=9MKuHHfYBgk:RbA3285iGCs:gIN9vFwOqvQ" border="0"&gt;&lt;/img&gt;&lt;/a&gt;
&lt;/div&gt;&lt;img src="http://feeds.feedburner.com/~r/LatestEpgOnlineNews/~4/9MKuHHfYBgk" height="1" width="1"/&gt;</description><feedburner:origLink>http://www.epgonline.org/news/2013/May/Early-prediction-of-Epilepticseizures.cfm</feedburner:origLink></item>

<item>
<title>Phase IIb study with STX 209 (Seaside Therapeutics) reports on efficacy in Autism Spectrum Disorder</title>
<link>http://feedproxy.google.com/~r/LatestEpgOnlineNews/~3/dvN3FMYaMfw/Phase-IIb-study-withSTX.cfm</link>
<category>Fragile X Syndrome</category>
<pubDate>Sat, 04 May 2013 00:05:00 GMT</pubDate>
<description>&lt;div class="feedflare"&gt;
&lt;a href="http://feeds.feedburner.com/~ff/LatestEpgOnlineNews?a=dvN3FMYaMfw:whfijav2LLg:yIl2AUoC8zA"&gt;&lt;img src="http://feeds.feedburner.com/~ff/LatestEpgOnlineNews?d=yIl2AUoC8zA" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/LatestEpgOnlineNews?a=dvN3FMYaMfw:whfijav2LLg:V_sGLiPBpWU"&gt;&lt;img src="http://feeds.feedburner.com/~ff/LatestEpgOnlineNews?i=dvN3FMYaMfw:whfijav2LLg:V_sGLiPBpWU" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/LatestEpgOnlineNews?a=dvN3FMYaMfw:whfijav2LLg:qj6IDK7rITs"&gt;&lt;img src="http://feeds.feedburner.com/~ff/LatestEpgOnlineNews?d=qj6IDK7rITs" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/LatestEpgOnlineNews?a=dvN3FMYaMfw:whfijav2LLg:gIN9vFwOqvQ"&gt;&lt;img src="http://feeds.feedburner.com/~ff/LatestEpgOnlineNews?i=dvN3FMYaMfw:whfijav2LLg:gIN9vFwOqvQ" border="0"&gt;&lt;/img&gt;&lt;/a&gt;
&lt;/div&gt;&lt;img src="http://feeds.feedburner.com/~r/LatestEpgOnlineNews/~4/dvN3FMYaMfw" height="1" width="1"/&gt;</description><feedburner:origLink>http://www.epgonline.org/news/2013/May/Phase-IIb-study-withSTX.cfm</feedburner:origLink></item>

<item>
<title>Phase III study of Sufentanil NanoTab PCA System (AcelRx Pharmaceuticals) shows superiority to morphine for Pain relief</title>
<link>http://feedproxy.google.com/~r/LatestEpgOnlineNews/~3/0EM6e7PwXHk/Phase-III-study-ofSufentanil.cfm</link>
<category>Pain:Post Operative</category>
<pubDate>Sat, 04 May 2013 00:05:00 GMT</pubDate>
<description>&lt;div class="feedflare"&gt;
&lt;a href="http://feeds.feedburner.com/~ff/LatestEpgOnlineNews?a=0EM6e7PwXHk:3zKnuyhwSoc:yIl2AUoC8zA"&gt;&lt;img src="http://feeds.feedburner.com/~ff/LatestEpgOnlineNews?d=yIl2AUoC8zA" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/LatestEpgOnlineNews?a=0EM6e7PwXHk:3zKnuyhwSoc:V_sGLiPBpWU"&gt;&lt;img src="http://feeds.feedburner.com/~ff/LatestEpgOnlineNews?i=0EM6e7PwXHk:3zKnuyhwSoc:V_sGLiPBpWU" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/LatestEpgOnlineNews?a=0EM6e7PwXHk:3zKnuyhwSoc:qj6IDK7rITs"&gt;&lt;img src="http://feeds.feedburner.com/~ff/LatestEpgOnlineNews?d=qj6IDK7rITs" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/LatestEpgOnlineNews?a=0EM6e7PwXHk:3zKnuyhwSoc:gIN9vFwOqvQ"&gt;&lt;img src="http://feeds.feedburner.com/~ff/LatestEpgOnlineNews?i=0EM6e7PwXHk:3zKnuyhwSoc:gIN9vFwOqvQ" border="0"&gt;&lt;/img&gt;&lt;/a&gt;
&lt;/div&gt;&lt;img src="http://feeds.feedburner.com/~r/LatestEpgOnlineNews/~4/0EM6e7PwXHk" height="1" width="1"/&gt;</description><feedburner:origLink>http://www.epgonline.org/news/2013/May/Phase-III-study-ofSufentanil.cfm</feedburner:origLink></item>

<item>
<title>FDA approves Vyvanse (Shire) as maintenance treatment  of ADHD for children and adolescents</title>
<link>http://feedproxy.google.com/~r/LatestEpgOnlineNews/~3/drR0KsGu96Y/FDA-approves-Vyvanse-Shire-as.cfm</link>
<category>ADHD</category>
<pubDate>Fri, 03 May 2013 00:05:00 GMT</pubDate>
<description>&lt;div class="feedflare"&gt;
&lt;a href="http://feeds.feedburner.com/~ff/LatestEpgOnlineNews?a=drR0KsGu96Y:kt3qxerLzx8:yIl2AUoC8zA"&gt;&lt;img src="http://feeds.feedburner.com/~ff/LatestEpgOnlineNews?d=yIl2AUoC8zA" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/LatestEpgOnlineNews?a=drR0KsGu96Y:kt3qxerLzx8:V_sGLiPBpWU"&gt;&lt;img src="http://feeds.feedburner.com/~ff/LatestEpgOnlineNews?i=drR0KsGu96Y:kt3qxerLzx8:V_sGLiPBpWU" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/LatestEpgOnlineNews?a=drR0KsGu96Y:kt3qxerLzx8:qj6IDK7rITs"&gt;&lt;img src="http://feeds.feedburner.com/~ff/LatestEpgOnlineNews?d=qj6IDK7rITs" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/LatestEpgOnlineNews?a=drR0KsGu96Y:kt3qxerLzx8:gIN9vFwOqvQ"&gt;&lt;img src="http://feeds.feedburner.com/~ff/LatestEpgOnlineNews?i=drR0KsGu96Y:kt3qxerLzx8:gIN9vFwOqvQ" border="0"&gt;&lt;/img&gt;&lt;/a&gt;
&lt;/div&gt;&lt;img src="http://feeds.feedburner.com/~r/LatestEpgOnlineNews/~4/drR0KsGu96Y" height="1" width="1"/&gt;</description><feedburner:origLink>http://www.epgonline.org/news/2013/May/FDA-approves-Vyvanse-Shire-as.cfm</feedburner:origLink></item>

<item>
<title>CHMP recommends Revlimid for treatment of Myelodysplastic Syndromes</title>
<link>http://feedproxy.google.com/~r/LatestEpgOnlineNews/~3/R577SLlpQ9s/CHMP-recommends-Revlimid-fortreatment.cfm</link>
<category>Myelodysplastic Syndromes</category>
<pubDate>Thu, 02 May 2013 00:05:00 GMT</pubDate>
<description>&lt;div class="feedflare"&gt;
&lt;a href="http://feeds.feedburner.com/~ff/LatestEpgOnlineNews?a=R577SLlpQ9s:Wr7FAaQ7d8U:yIl2AUoC8zA"&gt;&lt;img src="http://feeds.feedburner.com/~ff/LatestEpgOnlineNews?d=yIl2AUoC8zA" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/LatestEpgOnlineNews?a=R577SLlpQ9s:Wr7FAaQ7d8U:V_sGLiPBpWU"&gt;&lt;img src="http://feeds.feedburner.com/~ff/LatestEpgOnlineNews?i=R577SLlpQ9s:Wr7FAaQ7d8U:V_sGLiPBpWU" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/LatestEpgOnlineNews?a=R577SLlpQ9s:Wr7FAaQ7d8U:qj6IDK7rITs"&gt;&lt;img src="http://feeds.feedburner.com/~ff/LatestEpgOnlineNews?d=qj6IDK7rITs" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/LatestEpgOnlineNews?a=R577SLlpQ9s:Wr7FAaQ7d8U:gIN9vFwOqvQ"&gt;&lt;img src="http://feeds.feedburner.com/~ff/LatestEpgOnlineNews?i=R577SLlpQ9s:Wr7FAaQ7d8U:gIN9vFwOqvQ" border="0"&gt;&lt;/img&gt;&lt;/a&gt;
&lt;/div&gt;&lt;img src="http://feeds.feedburner.com/~r/LatestEpgOnlineNews/~4/R577SLlpQ9s" height="1" width="1"/&gt;</description><feedburner:origLink>http://www.epgonline.org/news/2013/May/CHMP-recommends-Revlimid-fortreatment.cfm</feedburner:origLink></item>

<item>
<title>FDA approves Procysbi (Raptor Pharmaceutical) for Nephropathic Cystinosis</title>
<link>http://feedproxy.google.com/~r/LatestEpgOnlineNews/~3/cGAFwZb01cc/FDA-approves-Procysbi-RaptorPharmaceutical-.cfm</link>
<category>Nephropathic Cystinosis</category>
<pubDate>Thu, 02 May 2013 00:05:00 GMT</pubDate>
<description>&lt;div class="feedflare"&gt;
&lt;a href="http://feeds.feedburner.com/~ff/LatestEpgOnlineNews?a=cGAFwZb01cc:5X2VDkpadFk:yIl2AUoC8zA"&gt;&lt;img src="http://feeds.feedburner.com/~ff/LatestEpgOnlineNews?d=yIl2AUoC8zA" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/LatestEpgOnlineNews?a=cGAFwZb01cc:5X2VDkpadFk:V_sGLiPBpWU"&gt;&lt;img src="http://feeds.feedburner.com/~ff/LatestEpgOnlineNews?i=cGAFwZb01cc:5X2VDkpadFk:V_sGLiPBpWU" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/LatestEpgOnlineNews?a=cGAFwZb01cc:5X2VDkpadFk:qj6IDK7rITs"&gt;&lt;img src="http://feeds.feedburner.com/~ff/LatestEpgOnlineNews?d=qj6IDK7rITs" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/LatestEpgOnlineNews?a=cGAFwZb01cc:5X2VDkpadFk:gIN9vFwOqvQ"&gt;&lt;img src="http://feeds.feedburner.com/~ff/LatestEpgOnlineNews?i=cGAFwZb01cc:5X2VDkpadFk:gIN9vFwOqvQ" border="0"&gt;&lt;/img&gt;&lt;/a&gt;
&lt;/div&gt;&lt;img src="http://feeds.feedburner.com/~r/LatestEpgOnlineNews/~4/cGAFwZb01cc" height="1" width="1"/&gt;</description><feedburner:origLink>http://www.epgonline.org/news/2013/May/FDA-approves-Procysbi-RaptorPharmaceutical-.cfm</feedburner:origLink></item>

<item>
<title>FDA approves Kcentra (CSL Behring)to reverse vitamin K antagonist anticoagulation with major bleeding</title>
<link>http://feedproxy.google.com/~r/LatestEpgOnlineNews/~3/CWtrfra2s1E/FDA-approves-Kcentra-CSLBehring-to.cfm</link>
<category>Bleeding</category>
<pubDate>Wed, 01 May 2013 00:05:00 GMT</pubDate>
<description>&lt;div class="feedflare"&gt;
&lt;a href="http://feeds.feedburner.com/~ff/LatestEpgOnlineNews?a=CWtrfra2s1E:8sPbHyh5MRA:yIl2AUoC8zA"&gt;&lt;img src="http://feeds.feedburner.com/~ff/LatestEpgOnlineNews?d=yIl2AUoC8zA" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/LatestEpgOnlineNews?a=CWtrfra2s1E:8sPbHyh5MRA:V_sGLiPBpWU"&gt;&lt;img src="http://feeds.feedburner.com/~ff/LatestEpgOnlineNews?i=CWtrfra2s1E:8sPbHyh5MRA:V_sGLiPBpWU" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/LatestEpgOnlineNews?a=CWtrfra2s1E:8sPbHyh5MRA:qj6IDK7rITs"&gt;&lt;img src="http://feeds.feedburner.com/~ff/LatestEpgOnlineNews?d=qj6IDK7rITs" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/LatestEpgOnlineNews?a=CWtrfra2s1E:8sPbHyh5MRA:gIN9vFwOqvQ"&gt;&lt;img src="http://feeds.feedburner.com/~ff/LatestEpgOnlineNews?i=CWtrfra2s1E:8sPbHyh5MRA:gIN9vFwOqvQ" border="0"&gt;&lt;/img&gt;&lt;/a&gt;
&lt;/div&gt;&lt;img src="http://feeds.feedburner.com/~r/LatestEpgOnlineNews/~4/CWtrfra2s1E" height="1" width="1"/&gt;</description><feedburner:origLink>http://www.epgonline.org/news/2013/May/FDA-approves-Kcentra-CSLBehring-to.cfm</feedburner:origLink></item>

<item>
<title>CHMP recommends Erivedge (Roche) for treatment of Basal Cell Carcinoma</title>
<link>http://feedproxy.google.com/~r/LatestEpgOnlineNews/~3/O-r4ez44Fjg/CHMP-recommends-Erivedge-Roche-for.cfm</link>
<category>Basal Cell Carcinoma</category>
<pubDate>Wed, 01 May 2013 00:05:00 GMT</pubDate>
<description>&lt;div class="feedflare"&gt;
&lt;a href="http://feeds.feedburner.com/~ff/LatestEpgOnlineNews?a=O-r4ez44Fjg:IH60tMM3HmA:yIl2AUoC8zA"&gt;&lt;img src="http://feeds.feedburner.com/~ff/LatestEpgOnlineNews?d=yIl2AUoC8zA" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/LatestEpgOnlineNews?a=O-r4ez44Fjg:IH60tMM3HmA:V_sGLiPBpWU"&gt;&lt;img src="http://feeds.feedburner.com/~ff/LatestEpgOnlineNews?i=O-r4ez44Fjg:IH60tMM3HmA:V_sGLiPBpWU" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/LatestEpgOnlineNews?a=O-r4ez44Fjg:IH60tMM3HmA:qj6IDK7rITs"&gt;&lt;img src="http://feeds.feedburner.com/~ff/LatestEpgOnlineNews?d=qj6IDK7rITs" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/LatestEpgOnlineNews?a=O-r4ez44Fjg:IH60tMM3HmA:gIN9vFwOqvQ"&gt;&lt;img src="http://feeds.feedburner.com/~ff/LatestEpgOnlineNews?i=O-r4ez44Fjg:IH60tMM3HmA:gIN9vFwOqvQ" border="0"&gt;&lt;/img&gt;&lt;/a&gt;
&lt;/div&gt;&lt;img src="http://feeds.feedburner.com/~r/LatestEpgOnlineNews/~4/O-r4ez44Fjg" height="1" width="1"/&gt;</description><feedburner:origLink>http://www.epgonline.org/news/2013/May/CHMP-recommends-Erivedge-Roche-for.cfm</feedburner:origLink></item>

<item>
<title>Phase II study of ORMD 0801 (Oramed Pharmaceuticals) successful for Type 1 Diabetes treatment</title>
<link>http://feedproxy.google.com/~r/LatestEpgOnlineNews/~3/q3O9hijRApU/Phase-II-study-ofORMD.cfm</link>
<category>Diabetes Types 1 &amp; 2</category>
<pubDate>Wed, 01 May 2013 00:05:00 GMT</pubDate>
<description>&lt;div class="feedflare"&gt;
&lt;a href="http://feeds.feedburner.com/~ff/LatestEpgOnlineNews?a=q3O9hijRApU:kJRLPoCJn7M:yIl2AUoC8zA"&gt;&lt;img src="http://feeds.feedburner.com/~ff/LatestEpgOnlineNews?d=yIl2AUoC8zA" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/LatestEpgOnlineNews?a=q3O9hijRApU:kJRLPoCJn7M:V_sGLiPBpWU"&gt;&lt;img src="http://feeds.feedburner.com/~ff/LatestEpgOnlineNews?i=q3O9hijRApU:kJRLPoCJn7M:V_sGLiPBpWU" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/LatestEpgOnlineNews?a=q3O9hijRApU:kJRLPoCJn7M:qj6IDK7rITs"&gt;&lt;img src="http://feeds.feedburner.com/~ff/LatestEpgOnlineNews?d=qj6IDK7rITs" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/LatestEpgOnlineNews?a=q3O9hijRApU:kJRLPoCJn7M:gIN9vFwOqvQ"&gt;&lt;img src="http://feeds.feedburner.com/~ff/LatestEpgOnlineNews?i=q3O9hijRApU:kJRLPoCJn7M:gIN9vFwOqvQ" border="0"&gt;&lt;/img&gt;&lt;/a&gt;
&lt;/div&gt;&lt;img src="http://feeds.feedburner.com/~r/LatestEpgOnlineNews/~4/q3O9hijRApU" height="1" width="1"/&gt;</description><feedburner:origLink>http://www.epgonline.org/news/2013/May/Phase-II-study-ofORMD.cfm</feedburner:origLink></item>

<item>
<title>FDA issues Complete Response Letters for elvitegravir and cobicistat (Gilead Sciences)</title>
<link>http://feedproxy.google.com/~r/LatestEpgOnlineNews/~3/oyKN09pfkmk/FDA-issues-Complete-ResponseLetters.cfm</link>
<category>HIV/AIDS</category>
<pubDate>Wed, 01 May 2013 00:05:00 GMT</pubDate>
<description>&lt;div class="feedflare"&gt;
&lt;a href="http://feeds.feedburner.com/~ff/LatestEpgOnlineNews?a=oyKN09pfkmk:0CxusYrb0vc:yIl2AUoC8zA"&gt;&lt;img src="http://feeds.feedburner.com/~ff/LatestEpgOnlineNews?d=yIl2AUoC8zA" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/LatestEpgOnlineNews?a=oyKN09pfkmk:0CxusYrb0vc:V_sGLiPBpWU"&gt;&lt;img src="http://feeds.feedburner.com/~ff/LatestEpgOnlineNews?i=oyKN09pfkmk:0CxusYrb0vc:V_sGLiPBpWU" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/LatestEpgOnlineNews?a=oyKN09pfkmk:0CxusYrb0vc:qj6IDK7rITs"&gt;&lt;img src="http://feeds.feedburner.com/~ff/LatestEpgOnlineNews?d=qj6IDK7rITs" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/LatestEpgOnlineNews?a=oyKN09pfkmk:0CxusYrb0vc:gIN9vFwOqvQ"&gt;&lt;img src="http://feeds.feedburner.com/~ff/LatestEpgOnlineNews?i=oyKN09pfkmk:0CxusYrb0vc:gIN9vFwOqvQ" border="0"&gt;&lt;/img&gt;&lt;/a&gt;
&lt;/div&gt;&lt;img src="http://feeds.feedburner.com/~r/LatestEpgOnlineNews/~4/oyKN09pfkmk" height="1" width="1"/&gt;</description><feedburner:origLink>http://www.epgonline.org/news/2013/May/FDA-issues-Complete-ResponseLetters.cfm</feedburner:origLink></item>

<item>
<title>Merck Inc and Pfizer to collaborate on ertugliflozin for Type 2 Diabetes</title>
<link>http://feedproxy.google.com/~r/LatestEpgOnlineNews/~3/b11A2_WyRiY/Merck-Inc-and-Pfizerto.cfm</link>
<category>Diabetes Type 2</category>
<pubDate>Tue, 30 Apr 2013 00:04:00 GMT</pubDate>
<description>&lt;div class="feedflare"&gt;
&lt;a href="http://feeds.feedburner.com/~ff/LatestEpgOnlineNews?a=b11A2_WyRiY:AI6UflvSSHQ:yIl2AUoC8zA"&gt;&lt;img src="http://feeds.feedburner.com/~ff/LatestEpgOnlineNews?d=yIl2AUoC8zA" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/LatestEpgOnlineNews?a=b11A2_WyRiY:AI6UflvSSHQ:V_sGLiPBpWU"&gt;&lt;img src="http://feeds.feedburner.com/~ff/LatestEpgOnlineNews?i=b11A2_WyRiY:AI6UflvSSHQ:V_sGLiPBpWU" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/LatestEpgOnlineNews?a=b11A2_WyRiY:AI6UflvSSHQ:qj6IDK7rITs"&gt;&lt;img src="http://feeds.feedburner.com/~ff/LatestEpgOnlineNews?d=qj6IDK7rITs" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/LatestEpgOnlineNews?a=b11A2_WyRiY:AI6UflvSSHQ:gIN9vFwOqvQ"&gt;&lt;img src="http://feeds.feedburner.com/~ff/LatestEpgOnlineNews?i=b11A2_WyRiY:AI6UflvSSHQ:gIN9vFwOqvQ" border="0"&gt;&lt;/img&gt;&lt;/a&gt;
&lt;/div&gt;&lt;img src="http://feeds.feedburner.com/~r/LatestEpgOnlineNews/~4/b11A2_WyRiY" height="1" width="1"/&gt;</description><feedburner:origLink>http://www.epgonline.org/news/2013/Apr/Merck-Inc-and-Pfizerto.cfm</feedburner:origLink></item>

<item>
<title>CHMP recommends Spedra (avanafil) as a treatment for Erectile Dysfunction in adult men</title>
<link>http://feedproxy.google.com/~r/LatestEpgOnlineNews/~3/HgEALq5NQzA/CHMP-recommends-Spedra.cfm</link>
<category>Erectile Dysfunction</category>
<pubDate>Tue, 30 Apr 2013 00:04:00 GMT</pubDate>
<description>&lt;div class="feedflare"&gt;
&lt;a href="http://feeds.feedburner.com/~ff/LatestEpgOnlineNews?a=HgEALq5NQzA:giLvPjVZm6k:yIl2AUoC8zA"&gt;&lt;img src="http://feeds.feedburner.com/~ff/LatestEpgOnlineNews?d=yIl2AUoC8zA" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/LatestEpgOnlineNews?a=HgEALq5NQzA:giLvPjVZm6k:V_sGLiPBpWU"&gt;&lt;img src="http://feeds.feedburner.com/~ff/LatestEpgOnlineNews?i=HgEALq5NQzA:giLvPjVZm6k:V_sGLiPBpWU" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/LatestEpgOnlineNews?a=HgEALq5NQzA:giLvPjVZm6k:qj6IDK7rITs"&gt;&lt;img src="http://feeds.feedburner.com/~ff/LatestEpgOnlineNews?d=qj6IDK7rITs" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/LatestEpgOnlineNews?a=HgEALq5NQzA:giLvPjVZm6k:gIN9vFwOqvQ"&gt;&lt;img src="http://feeds.feedburner.com/~ff/LatestEpgOnlineNews?i=HgEALq5NQzA:giLvPjVZm6k:gIN9vFwOqvQ" border="0"&gt;&lt;/img&gt;&lt;/a&gt;
&lt;/div&gt;&lt;img src="http://feeds.feedburner.com/~r/LatestEpgOnlineNews/~4/HgEALq5NQzA" height="1" width="1"/&gt;</description><feedburner:origLink>http://www.epgonline.org/news/2013/Apr/CHMP-recommends-Spedra.cfm</feedburner:origLink></item>

<item>
<title>BioMarin files Vimzim at EMA for Mucopolysaccharidosis Type IVA</title>
<link>http://feedproxy.google.com/~r/LatestEpgOnlineNews/~3/e4VsQQqYYZE/BioMarin-files-Vimzim-atEMA.cfm</link>
<category>MPS IV A</category>
<pubDate>Mon, 29 Apr 2013 00:04:00 GMT</pubDate>
<description>&lt;div class="feedflare"&gt;
&lt;a href="http://feeds.feedburner.com/~ff/LatestEpgOnlineNews?a=e4VsQQqYYZE:iFV1fSK5O2g:yIl2AUoC8zA"&gt;&lt;img src="http://feeds.feedburner.com/~ff/LatestEpgOnlineNews?d=yIl2AUoC8zA" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/LatestEpgOnlineNews?a=e4VsQQqYYZE:iFV1fSK5O2g:V_sGLiPBpWU"&gt;&lt;img src="http://feeds.feedburner.com/~ff/LatestEpgOnlineNews?i=e4VsQQqYYZE:iFV1fSK5O2g:V_sGLiPBpWU" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/LatestEpgOnlineNews?a=e4VsQQqYYZE:iFV1fSK5O2g:qj6IDK7rITs"&gt;&lt;img src="http://feeds.feedburner.com/~ff/LatestEpgOnlineNews?d=qj6IDK7rITs" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/LatestEpgOnlineNews?a=e4VsQQqYYZE:iFV1fSK5O2g:gIN9vFwOqvQ"&gt;&lt;img src="http://feeds.feedburner.com/~ff/LatestEpgOnlineNews?i=e4VsQQqYYZE:iFV1fSK5O2g:gIN9vFwOqvQ" border="0"&gt;&lt;/img&gt;&lt;/a&gt;
&lt;/div&gt;&lt;img src="http://feeds.feedburner.com/~r/LatestEpgOnlineNews/~4/e4VsQQqYYZE" height="1" width="1"/&gt;</description><feedburner:origLink>http://www.epgonline.org/news/2013/Apr/BioMarin-files-Vimzim-atEMA.cfm</feedburner:origLink></item>

<item>
<title>CHMP recommends approval of Nuedexta (Avanir Pharma) for Pseudo Bulbar Affect</title>
<link>http://feedproxy.google.com/~r/LatestEpgOnlineNews/~3/gh8-LgtqJTk/CHMP-recommends-approval-ofNuedexta.cfm</link>
<category>Pseudo Bulbar Affect</category>
<pubDate>Sun, 28 Apr 2013 00:04:00 GMT</pubDate>
<description>&lt;div class="feedflare"&gt;
&lt;a href="http://feeds.feedburner.com/~ff/LatestEpgOnlineNews?a=gh8-LgtqJTk:UB5WEjEr-eA:yIl2AUoC8zA"&gt;&lt;img src="http://feeds.feedburner.com/~ff/LatestEpgOnlineNews?d=yIl2AUoC8zA" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/LatestEpgOnlineNews?a=gh8-LgtqJTk:UB5WEjEr-eA:V_sGLiPBpWU"&gt;&lt;img src="http://feeds.feedburner.com/~ff/LatestEpgOnlineNews?i=gh8-LgtqJTk:UB5WEjEr-eA:V_sGLiPBpWU" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/LatestEpgOnlineNews?a=gh8-LgtqJTk:UB5WEjEr-eA:qj6IDK7rITs"&gt;&lt;img src="http://feeds.feedburner.com/~ff/LatestEpgOnlineNews?d=qj6IDK7rITs" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/LatestEpgOnlineNews?a=gh8-LgtqJTk:UB5WEjEr-eA:gIN9vFwOqvQ"&gt;&lt;img src="http://feeds.feedburner.com/~ff/LatestEpgOnlineNews?i=gh8-LgtqJTk:UB5WEjEr-eA:gIN9vFwOqvQ" border="0"&gt;&lt;/img&gt;&lt;/a&gt;
&lt;/div&gt;&lt;img src="http://feeds.feedburner.com/~r/LatestEpgOnlineNews/~4/gh8-LgtqJTk" height="1" width="1"/&gt;</description><feedburner:origLink>http://www.epgonline.org/news/2013/Apr/CHMP-recommends-approval-ofNuedexta.cfm</feedburner:origLink></item>

<item>
<title>Phase II data show CEM 101 (Cempra Inc) useful against urogenital Infections and multidrug-resistant pathogens</title>
<link>http://feedproxy.google.com/~r/LatestEpgOnlineNews/~3/5NySRBmYjgY/Phase-II-data-showCEM.cfm</link>
<category>Infectious Diseases/N.gonorrhoeae</category>
<pubDate>Sun, 28 Apr 2013 00:04:00 GMT</pubDate>
<description>&lt;div class="feedflare"&gt;
&lt;a href="http://feeds.feedburner.com/~ff/LatestEpgOnlineNews?a=5NySRBmYjgY:J2VUW0ft73w:yIl2AUoC8zA"&gt;&lt;img src="http://feeds.feedburner.com/~ff/LatestEpgOnlineNews?d=yIl2AUoC8zA" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/LatestEpgOnlineNews?a=5NySRBmYjgY:J2VUW0ft73w:V_sGLiPBpWU"&gt;&lt;img src="http://feeds.feedburner.com/~ff/LatestEpgOnlineNews?i=5NySRBmYjgY:J2VUW0ft73w:V_sGLiPBpWU" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/LatestEpgOnlineNews?a=5NySRBmYjgY:J2VUW0ft73w:qj6IDK7rITs"&gt;&lt;img src="http://feeds.feedburner.com/~ff/LatestEpgOnlineNews?d=qj6IDK7rITs" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/LatestEpgOnlineNews?a=5NySRBmYjgY:J2VUW0ft73w:gIN9vFwOqvQ"&gt;&lt;img src="http://feeds.feedburner.com/~ff/LatestEpgOnlineNews?i=5NySRBmYjgY:J2VUW0ft73w:gIN9vFwOqvQ" border="0"&gt;&lt;/img&gt;&lt;/a&gt;
&lt;/div&gt;&lt;img src="http://feeds.feedburner.com/~r/LatestEpgOnlineNews/~4/5NySRBmYjgY" height="1" width="1"/&gt;</description><feedburner:origLink>http://www.epgonline.org/news/2013/Apr/Phase-II-data-showCEM.cfm</feedburner:origLink></item>

</channel></rss>
